We would love to hear your thoughts about our site and services, please take our survey here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAEFS.L Regulatory News (AEFS)

  • There is currently no data for AEFS

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Annual Financial Report

28 Jun 2017 09:27

RNS Number : 4096J
Alcentra European Fltng Rate Inc Fd
28 June 2017
 

Alcentra European Floating Rate Income Fund Limited

 

28 JUNE 2017

 

FOR IMMEDIATE RELEASE

 

THE BOARD OF DIRECTORS OF ALCENTRA EUROPEAN FLOATING RATE INCOME FUND LIMITED ANNOUNCES THE ANNUAL REPORT AND AUDITED FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 MARCH 2017.

 

Strategic Report 

 

Financial Highlights and Performance Summary

 

Financial Highlights

 

Alcentra European Floating Rate Income Fund Limited (the "Company") repurchased and cancelled 6,365,065 Ordinary Shares during the year for a total cost of €7,564,758 (£6,345,793). Nil Ordinary Shares were repurchased or cancelled during the year ended 31 March 2016.

 

Performance Summary

(In millions, except per share data and the number of Ordinary Shares in issue)

At 31 March 2017

At 31 March 2016

Number of Ordinary Shares in issue

169,610,896

175,975,961

Market capitalisation1

- Ordinary Shares (in Sterling)

£174.7

£177.3

- Ordinary Shares (in Euro)

€204.8

€224.2

Net Asset Value ("NAV") attributable to Sterling shareholders

- Ordinary Shares

€207.1

€229.3

NAV per share attributable to Sterling shareholders

- Ordinary Shares (in Sterling)

£1.0414

£1.0304

- Ordinary Shares (in Euro)

€1.2210

€1.3031

Ordinary Share price (bid price)1

In Sterling

£1.0300

£1.0075

In Euro

€1.2076

€1.2741

Ordinary Share price discount to NAV

In Sterling

£0.0114

£0.0229

In Euro

€0.0134

€0.0290

Investment in Alcentra European Floating Rate Income S.A. at fair value

€203.9

€229.4

Cash and cash equivalents

€1.1

€1.8

Dividend yield - Ordinary Shares

5.34%

5.24%

 

Ongoing Charges

The ongoing charge reflects those expenses of a type which are likely to recur in the foreseeable future and which relate to the operation of the Company, excluding the costs of acquisition or disposal of investments, finance charges, gains or losses arising on investments and Ordinary Shares.

 

The ongoing charge is a measure, expressed as a percentage of NAV, based on actual costs incurred in the year as being the best estimate of future costs excluding any non-recurring fees divided by the average NAV of the Company during the year, in accordance with the Association of Investment Companies (the "AIC") methodology. The ongoing charge for the year ended 31 March 2017 was 1.03% (31 March 2016: 1.04%).

 

Dividend History

Please refer to note 10 for details on dividends paid during the year.

 

1  Source: London Stock Exchange

 

Chairman's Statement

 

Dear Shareholder,

 

I'm pleased to present the Annual Report of Alcentra European Floating Rate Income Fund Limited (the "Company") for the year ended 31 March 2017.

 

The Company demonstrated NAV growth over the past year with the NAV per share increasing from 103.04p as at 31 March 2016 to 104.14p as at 31 March 2017. In relation to the period, the Company declared and paid dividends of 5.5p per Ordinary share and subsequent to the period end declared and paid a dividend of 1.09p. As at the date of approval of the audited financial statements, total dividend paid since inception is 26.32p per Ordinary share, giving an overall total return since inception of 33.12%, annualised at 5.6%.

 

The Board actively monitors the share price, working closely with the Company's brokers within an agreed framework. We have instigated a buyback programme with the aim of limiting the discount to NAV. During the period, 6,365,065 Ordinary shares were repurchased and cancelled, bringing the issued share capital of the Company to 169,610,896 Ordinary Shares. Subsequent to the year end, a further 3,240,496 Ordinary Shares have been repurchased and cancelled. The buyback transactions are so far proving successful in limiting the discount to NAV.

 

The Company invests in senior secured loans and senior secured bonds issued by European corporates and has additional capacity to invest in mezzanine loans and other debt securities. The highly diversified portfolio of well managed credits has yielded stable dividends over the four years since inception. The Company targets long term returns (net of fees and expenses) in excess of 5% per annum and will continue to pay quarterly dividends. The near term outlook in the global credit market is for continuing spread compression which is likely to put pressure on returns. The board is monitoring the situation and maintains confidence in the asset class owing to its floating rate nature and has the ability to benefit from future interest rate rises.

 

The Board closely monitors the markets in the current environment, including the consequences of the Brexit vote, within the risk management framework that has been established by the Risk Committee. Whilst the impact of Brexit remains unknown, continued currency volatility is expected. Nevertheless, your Board remains confident in the Company's portfolio comprised of well-selected, robust credits and with the Investment Manager will continue to seek opportunities in our markets to add further value.

 

Alcentra Limited (the "Investment Manager") believes that the loan market performance over 2016 to date, given the level of financial markets volatility, demonstrates that the loan market continues to provide attractive risk adjusted returns compared to other asset classes. Your Board continues to be satisfied with the portfolio's performance to date and the strategy that is being applied by the Investment Manager. The Investment Manager will continue to update you on the Company's progress by way of the monthly performance updates.

 

On behalf of the Board, I would like to close by thanking shareholders for your continued commitment and I look forward to updating you on the Company's progress later on this year.

 

Ian Fitzgerald

Chairman

 

27 June 2017

 

Executive Summary

 

This report is designed to provide information about the business and results for the year ended 31 March 2017 for the Company. It should be read in conjunction with the Chairman's Statement and the Investment Manager's report which give a detailed review of investment activities for the year and an outlook for the future.

 

Corporate Summary

The Company is a non-cellular company limited by shares incorporated in Guernsey on 3 November 2011 under the Companies (Guernsey) Law, 2008, (as amended) (the "Companies Law"), with registration number 54200. The Company has been authorised by the Guernsey Financial Services Commission (the "GFSC") as an authorised closed-ended collective investment scheme.

 

The Initial Public Offering of the Company took place on 29 February 2012 and the Company commenced business on 6 March 2012, when its Ordinary Shares were admitted to the premium segment of the Financial Conduct Authority's (the "FCA") Official List and to trading on the Main Market of the London Stock Exchange. For details on the Company's share capital refer to note 9.

 

The issued share capital of the Company as at 31 March 2017 was 169,610,896 (31 March 2016: 175,975,961) Ordinary Shares, which are denominated in Sterling.

 

The Company has a wholly-owned subsidiary Alcentra European Floating Rate Income S.A. (the "Subsidiary").

 

The Company is a member of the AIC.

 

Culture of the Company

The Board recognises the importance of a strong corporate governance culture that meets the requirements of the UK Governance framework, including the UK Listing Authority as well as other relevant bodies such as the GFSC and the AIC of which the Company is a member.

 

Significant Events During the Year Ended 31 March 2017

The Company repurchased and cancelled 6,365,065 Ordinary Shares during the year for a total cost of €7,564,758 (£6,345,793).

 

Investment Manager

Alcentra Limited is the investment manager (the "Investment Manager"), a company incorporated in England and Wales on 4 March 2003, with registration number 2958399. The Investment Manager is regulated by the UK's Financial Conduct Authority and registered as an investment adviser with the US Securities and Exchange Commission.

 

Investment Objective

The investment objective of the Company is to provide its shareholders with regular quarterly dividends and the opportunity for capital growth by utilising the skills of the Investment Manager in selecting suitable investments.

 

The Company, together with the Subsidiary, as advised by the Investment Manager, invests either directly or, through sub-participation, indirectly in floating rate, secured loans or high-yield bonds issued by European and US corporate entities predominantly rated below investment grade or deemed by the Investment Manager to be of a corresponding credit quality.

 

The Company aims to satisfy the guideline in its investment policy that at least 80% of its investments are to be in debt obligations of corporate entities with significant operations, or which are domiciled, in Western Europe (including the United Kingdom). Investments are expected to be denominated in Euro, Sterling or US Dollars. 

 

Investment Policy

The Investment Manager will select, from the primary and secondary markets, investments for the Company in the following asset classes (which may be considered to be non-investment grade):

 

• secured loans, including senior loans, mezzanine loans and second lien loans;

• senior secured floating-rate notes; and

• senior secured and senior unsecured high-yield bonds,

 

The Investment Manager will seek to identify investment opportunities that combine an attractive current return with a strong probability of ultimate return of capital.

 

Diversification

The Company expects to maintain a diversified portfolio by asset class, issuer concentration, industry concentration and geographical exposure (the "Portfolio"). The Company does not include in its investment policy any exclusion of particular industry sectors. The Portfolio complies with the following restrictions (at each date an investment is made by the Company):

 

• at least 80% of the Company's NAV in senior loans, senior secured floating-rate notes and cash;

• no more than 20% of the Company's NAV in second lien loans and mezzanine loans; and

• no more than 5% exposure to any single obligor.

 

In addition, the Company will aim to satisfy the following guideline criteria for the Portfolio:

 

• no more than 15% of the Company's NAV in unsecured floating-rate notes, secured or unsecured fixed rate bonds or structured credit instruments;

• no more than 20% exposure to any single industry sector; and

• at least 80% exposure to corporate entities with significant operations, or which are domiciled, in Western Europe (including the United Kingdom).

 

Key Performance Indicators

In order to measure the success of the Company in meeting its objectives and to evaluate the performance of the Investment Manager, the Directors take into account the following performance indicators:

 

Returns and NAV

The Board reviews and compares, at each meeting, the NAV and Ordinary Share price of the Company. The Directors regard the Company's NAV total return as being the overall measure of value delivered to shareholders over the long term. Total return reflects both NAV growth of the Company and also dividends paid to shareholders. The Company targets a NAV total return in excess of 5% per annum over the longer term.

 

The NAV total return of the Company's Ordinary Shares was 33.12% from inception. Please refer to the Financial Highlights and Performance Summary for NAV and share price analysis.

 

Discount/Premium to NAV

At each Board meeting, the Board monitors the level of the Company's discount or premium to NAV and reviews the average discount/premium for the Company's peer company. The Company publishes its NAV per share on a daily basis via the Regulatory News Service ("RNS") of the London Stock Exchange. This figure is calculated in accordance with the AIC formula which includes current financial year revenue; the same basis as that calculated for the audited financial statements. Please refer to the Financial Highlights and Performance Summary for NAV and share price analysis.

 

Dividend Yield

The Board examine the revenue forecast quarterly and consider the yield on the Portfolio and the amount available for distribution. The dividend yield is detailed in the Financial Highlights and Performance Summary.

 

Benchmark Performance

The Board considers the peer company performance of other income funds at each quarterly Board meeting. Please refer to the Investment Manager's Report for performance summary, market review and outlook.

 

Key Risks and Uncertainties

The Board is responsible for the Company's system of internal controls and for reviewing its effectiveness. The Board also monitors the investment limits and restrictions set out in the Company's investment objective and policy.

 

The key risks that have been identified and the steps taken by the Board to mitigate these are as follows:

 

Investment Activity and Performance

An inappropriate investment strategy may result in under-performance against the Company's objectives. The Board manages these risks by ensuring a diversification of investments. The Investment Manager operates in accordance with the investment limits and restrictions policy determined by the Board. The Board review the limits and restrictions on a regular basis and BNP Paribas S.C.A., Guernsey Branch (the "Administrator" and the "Custodian") monitors adherence to the limits and restrictions every month and will notify any breaches to the Board.

 

The Investment Manager provides the Board with management information including performance data and reports. The Directors monitor the implementation and results of the investment process with the Investment Manager at each Board meeting and monitor risk factors in respect of the portfolio. Investment strategy is reviewed at each meeting. Please refer to the Investment Manager's Report for performance summary, market review and outlook.

 

Level of discount or premium

A discount or premium to NAV can occur for a variety of reasons, including market conditions or to the extent investors undervalue the management activities of the Investment Manager or discount their valuation methodology and judgement. While the Board may seek to mitigate any discount to NAV per Ordinary Share through the discount management mechanisms set out in the Prospectus, there can be no guarantee that they will do so or that such mechanisms will be successful and the Directors accept no responsibility for any failure of any such strategy to effect a reduction in any discount or premium.

 

Market price risk

The market value of the Portfolio may vary because of a number of factors, including, but not limited to, the financial condition of the underlying borrowers, the industry in which a borrower operates, general economic or political conditions, interest rates, the condition of the debt trading markets and certain other financial markets, developments or trends in any particular industry and changes in prevailing interest rates. The Investment Manager carries out extensive due diligence on each borrower which is subsequently assessed by its credit committee to mitigate this risk.

 

Accounting, legal and regulatory

The Company must comply with the provisions of the Companies Law and, since its shares are admitted to listing on the FCA's Official List and to trading on the Main Market of the London Stock Exchange, the Company is subject to the Listing Rules of the FCA (the "Listing Rules") and the Disclosure Guidance and Transparency Rules of the FCA (the "DTR"). A breach of the legislation could result in the Company and/or the Directors being fined or subject to criminal proceedings. A breach of the Listing Rules could result in the suspension of the Company's shares. The Board relies on its company secretary and advisers to ensure adherence to the Guernsey legislation and the FCA's rules.

 

The Investment Manager and the Administrator are contracted to provide investment, company secretarial, administration and accounting services through qualified professionals. The Board receives regular internal control reports from the Administrator that confirm compliance. The Subsidiary, which is incorporated in Luxembourg, must comply with the local regulatory and statutory rules and requirements. The Board relies on the Investment Manager and advisers to the Subsidiary to ensure the Subsidiary adheres to Luxembourg legislation.

 

Operational

Disruption to, or the failure of, either the Investment Manager's or the Administrator's accounting, dealings or payment systems, or the custodian's records could prevent the accurate reporting or monitoring of the Company's financial position.

 

Details of how the Board monitors the services provided by the Investment Manager and the Administrator, and the key elements designed to provide effective internal control are explained further in the Internal Controls and Risk Management section in the Directors' Report.

 

Viability Statement

Under the AIC Code, the Directors are required to make a viability statement which explains how they have assessed the prospects of the Company, over what period they have done so and why they consider that period to be appropriate, taking into account the Company's current position and principal risks. The key risks faced by the Company are described in the Executive Summary.

 

The Directors have conducted a robust assessment of the viability of the Company over a five year period, taking account of the Company's current position and the potential impact of the principal risks outlined above. This statement is made on the assumption that continuation votes will be passed throughout the period under assessment.

 

In making this statement, the Directors have considered the resilience of the Company, taking into account its current position, the principal risks facing the Company in severe but reasonable scenarios and the effectiveness of any mitigating actions. This assessment has considered the potential impacts of these risks on the business model, future performance, solvency and liquidity over the period.

 

The Directors have determined that a five year period is an appropriate period over which to provide its viability statement as this best suits the average weighted life of the portfolio.

 

In making their assessment, factors taken into consideration by the Directors included the Company's NAV, net income, resulting cash flows and dividend cover over the period. These factors were subjected to stress tests which involved sensitivity analysis of the key assumptions underlying the forecast. Where appropriate, this analysis was carried out to evaluate the potential impact of the Company's principal risks actually occurring, primarily, severe changes to macro-economic conditions, increased defaults and counterparty risks.

 

Based on this assessment, the Directors have a reasonable expectation that the Company will be able to continue in operation and meet its liabilities as they fall due over the five year period to 27 June 2022.

 

Discount Control Mechanism

As per the Articles of Incorporation, under the discount control mechanism, if, as at 31 March, 30 June, 30 September or 31 December in any calendar year, the Ordinary Shares of any class in issue have, on average over the last twelve calendar months preceding such date (a ''Discount Calculation Period''), traded at an average discount in excess of 5% of the NAV per share of that class1, the Directors will, subject to any legal or regulatory requirements, implement a redemption offer (a ''Redemption Offer'') pursuant to which each shareholder of the relevant class shall be permitted to redeem up to 50% of their Ordinary Shares of that class. No more than one Redemption Offer shall be made in respect of any class of Ordinary Share in a twelve month period.

 

The Company's Ordinary Shares did not trade at an average discount in excess of 5% of the NAV per Ordinary Share at any calendar quarter end during the year ended 31 March 2017.

 

1 Calculated by reference to the middle market quotations of the shares of that class on the Daily Official List of the London Stock Exchange on each trading day in the relevant Discount Calculation Period and the most recently published NAV per share of the relevant class for each such trading day.

 

Share Buybacks

The Directors operate an active discount management policy through the use of share buybacks. On 21 September 2016, the Directors were granted authority to repurchase 26,378,796 Shares for cancellation or to be held as treasury shares. This authority will expire at the next Annual General Meeting of the Company (the "AGM") which will be held on 20 September 2017. The Directors intend to seek annual renewal of this authority from the shareholders.

 

Pursuant to this authority, and subject to the Companies Law and the discretion of the Directors, the Company may purchase Ordinary Shares in the market on an on-going basis with a view to addressing any imbalance between the supply of and demand for Ordinary Shares, thereby increasing the NAV per Ordinary Share and assisting in controlling the discount to NAV per Ordinary Share in relation to the price at which the Ordinary Shares may be trading.

 

Please refer to note 9 for details of Ordinary Share buybacks during the year ended 31 March 2017.

 

Environmental and Social Issues

The Company is a closed-ended investment company which has no employees and therefore its own direct environmental impact is minimal. The Board notes that the companies in which the Company invests in will have a social and environmental impact over which it has no control. The Board, the majority of whom are based in Guernsey, have held all their meetings in Guernsey and therefore the Company's greenhouse gas emissions and environmental footprint are negligible.

 

Gender Metrics

The Board consists of one woman and two men. More information on the Board's consideration of diversity is given in the Corporate Governance Report.

 

Life of the Company

The Company does not have a fixed life. In accordance with the Articles of Incorporation, a continuation resolution to propose that the Company continues its business as a closed-ended investment company was passed at the AGM on 25 September 2014.

 

The Directors are next required to convene a general meeting to propose a further continuation resolution on or before the sixth anniversary of the date that the Ordinary Shares of the Company were listed on the Official List of the FCA and to trading on the London Stock Exchange, being 6 March 2018. The next continuation resolution will be considered at the AGM on 20 September 2017. The Directors shall convene a general meeting to propose a further continuation resolution every year thereafter.

 

If the continuation resolution is not passed, the Directors shall put proposals to shareholders for the reconstruction or reorganisation of the Company.

 

Future Strategy

While the future performance of the Company is dependent, to a large degree, on the performance of international financial markets which, in turn, are subject to many external factors, the Board's intention is that the Company will continue to pursue its stated investment objective as outlined in the Executive Summary. Further comments on the outlook for the Company for the next twelve months are set out in both the Chairman's Statement and the Investment Manager's Report.

 

Going Concern

Under the Code of Corporate Governance issued by the AIC in July 2016 and applicable regulations, the Directors are required to satisfy themselves that it is reasonable to assume that the Company is a going concern from the date of approval of the audited financial statements.

 

After analysing the following, the Directors believe that it is appropriate to adopt the going concern basis in preparing these audited financial statements:

 

1. Working capital - As at 31 March 2017, the working capital surplus in the Company was approximately €3.2 million. The Company has the ability to sell bonds in the Subsidiary and/or request repayment of accrued interest. The Subsidiary has a working capital surplus of approximately €1.4 million. The Directors noted that as at 31 March 2017, the Company had no borrowings. As such it has sufficient capital in hand to cover all expenses (which mainly consist of Investment Manager's fees, administration fees and professional fees) and to meet all of its obligations as they fall due.

 

2. Closed-ended company - The Company has been registered with the GFSC as a registered closed-ended collective investment scheme, as such shareholders have no right to have their Ordinary Shares redeemed, and therefore no cash flows out of the Company in this respect.

 

3. In accordance with the Articles of Incorporation a continuation resolution was passed at the AGM on 25 September 2014. The next continuation resolution will be considered at the AGM on 20 September 2017 and the Directors' going concern assessment assumes that the continuation vote will be passed. If the continuation resolution is not passed, the Directors shall put proposals to the shareholders for the reconstruction and reorganisation of the Company.

 

4. Discount Control Mechanism - the Company's Ordinary Shares did not trade at an average discount in excess of 5% of the NAV per share over the Discount Calculation Period ended 31 March 2017 and as a result the Discount Control Mechanism has not been triggered. The Company has repurchased Ordinary Shares in the market for cancellation to assist in controlling the discount in the Ordinary Share price to NAV per Ordinary Share. Although the Board operates an active discount management policy to mitigate any discount to NAV per share, there can be no guarantee that they will do so or that such mechanisms will be successful. Please refer to the Executive Summary for details regarding the Discount Control Mechanism and Redemption Offer and note 9 for details of Ordinary Share buybacks.

 

Taking into consideration the analysis detailed above, the Company's ability to meet its liabilities as they fall due and reasonably manage any uncertainties as they arise, and after making enquiries of the Company's Investment Manager and Corporate Brokers, the Directors are satisfied that it is appropriate to continue to prepare the financial statements on a going concern basis.

 

This Strategic Report was approved by the Board of Directors on 27 June 2017 and signed on its behalf by:

 

Ian Fitzgerald Jonathan Bridel

Chairman Audit Committee Chairman

 

Investment Manager's Report

 

Summary

 

The NAV of the Company has remained relatively stable over the year, although there was some short term volatility through the Brexit vote at the end of June 2016 until early July 2016. However, this volatility proved to be short lived as confidence quickly returned to the loan market and appetite has been robust through the remainder of the year.

 

The AEFS share price (AEFS is the Bloomberg ticker for the Company) saw some weakness earlier in the year, following a trend of similar discounts appearing in US loan funds in 2015. Over the second half of the year the share price performed well and discount narrowed, as the market increasingly appreciated loans resilient performance and attractive yield when compared to other asset classes. The widening of the discount at periods during the year has allowed the Board to buy back 6,365,065 Ordinary Shares over the year, providing liquidity to those investors requiring it while benefitting the remaining holders of the stock.

 

As at 31 March 2017, the NAV was 104.14 pence per Ordinary Share.

 

Note on Foreign Exchange Hedging in period

 

The Company maintains its account in EUR and with the outstanding Ordinary Shares in issue solely denominated in GBP the Company actively hedges this risk by utilising FX forward contracts. Given the volatility in the EURGBP exchange rate in the year, with GBP declining 7.29%, the Company therefore generated significant hedging losses which offset the currency appreciation of the non GBP assets. Whilst these hedging losses create an operating loss on the Statement of Comprehensive Income in the period it should be noted that in GBP terms investor returns were positive with the GBP NAV per share appreciating from £1.0304 to £1.0414 in addition to dividends distributed.

 

Portfolio

 

As at 31 March 2017, the portfolio was invested in line with the Company's investment policy and was diversified by obligor and industry with 100 issuers/borrowers across 28 different industry sectors and no individual borrower representing an exposure of more than 5 percent of the portfolio. Against a volatile financial markets backdrop over the past few years, the Company's performance has been strong, outperforming both US and European loan indices, as shown below:

 

Portfolio Statistics as at 31 March 2017

Weighted Average Mark

99.01

Weighted Average Maturity

5.29

Weighted Average YTM

5.67%

Weighted Average Current Yield

5.20%

Floating Rate Assets (in cash)

92.86%

No. of Issuers

100

No of Investments

125

No. of Industries

28

Weighted Average Coupon

5.96%

Weighted Average Floating Rate Plus Margin

4.95%

 

Portfolio Statistics as at 31 March 2017

 

Below are tables highlighting key aspects of the portfolio as at 31 March 2017.

 

10 Largest Holdings

Issuer

% of NAV

Currency

Country

Eircom

3.36

EUR

Ireland

Numericable

3.14

EUR & USD

France

Motor Fuel Group

2.56

GBP

UK

ERM

2.53

USD

UK

Diaverum

2.21

EUR

Luxembourg

Bureau Van Dijk

1.97

GBP

Netherlands

Verallia

1.93

EUR

France

Oberthur Technologies

1.93

EUR

France

 Cabot Financial Lux SA

1.91 

GBP

United States 

Vivarte

1.73

EUR

France

 

5 Largest Industry Positions

Issuer

% of NAV

Business Equipment and Services

12.14

Health Care

11.53

Telecoms

7.47

Retailers (other than food/drug)

7.10

Cable Television

7.02

 

Asset Breakdown

% of NAV

Senior secured loans

76.14

Senior secured FRNs

11.34

Mezzanine loans

2.63

Second lien loans

1.65

Senior secured bonds

5.59

Senior unsecured bonds

1.55

Cash

1.10

 

Currency Breakdown

% of NAV

Euro

66.53

Pound Sterling

25.24

US Dollar

7.13

Cash

1.10

 

Performance

 

Since inception the portfolio has evolved as follows:

 

· Increased the number of assets from 47 to 125 improving further diversity within the portfolio.

· Remained well diversified by sector and geography.

· Maintained the high UK exposure to take advantage of the better margins available for Sterling loans.

· Not significantly increased US exposure, given better total return on non-US Dollar tranches on cross-border deals.

 

Geographical Region (31 March 2017)

Country

% of NAV

United Kingdom

33.74

France

15.10

Netherlands

10.74

Germany

8.84

United States

6.19

Luxembourg

5.11

Sweden

4.49

Spain

4.36

Ireland

4.16

Other

6.17

Cash

1.10

 

Geographical Region (as at completion of initial investment - 30 April 2012)

 

Country

% of NAV

UK

44.29%

France

27.95%

Sweden

6.59%

USA

4.11%

Netherlands

3.10%

Germany

3.09%

Belgium

2.05%

Luxembourg

1.05%

Cash

7.77%

 

Outlook

 

Key attractions of Floating Rate Secured Loans and Bonds:

 

§ In 1Q 2017 the average new issue spread was E+ 3.60%2

§ Senior secured, so lower risk of loss in the event of default than unsecured asset classes

§ Low market default rates (1.73%)3

§ Active new issue market with €34 billion issued in Q1 20175 and a liquid secondary market with over €11.7 billion traded in Q4 20164

§ Low secondary market price volatility compared to other asset classes

§ Floating rate income benefiting from a future interest rate rise

 

2Standard & Poor's Global Leveraged Lending Review 1Q2017.

3 Credit Suisse Leveraged Finance Default Review, 25 April 2016.

4 Standard & Poor's LCD Global Leveraged Lending Review 1Q2017.

Past performance is not a guide to future performance

 

Historical Defaults and Outlook

 

Expected defaults are more easily identified

 

§ Defaults stayed relatively low during the period with S&P's default rate at 1.73% in March 2017, versus 2.12% at the end of 201555. The Fund had no defaults in 2016 and has had no impairments from defaults since inception.

§ S&P's Distress Ratio (which measures the percentage of the S&P ELLI trading below 80) had fallen to 1.72% in November, the lowest reading since December 2007. This compares with 2.88% in December 2015. This is normally a good indicator of future defaults but will also be influenced by secondary loan price improvements from increased investor demand.6

§ Average leverage multiples finished the year in line with where they were at the beginning (approx. 5.5x), so the increased loan demand has, to date, had more impact on weaker loan documentation (weaker covenants) than it has on aggressive leverage.7 

§ One disappointment for 2016 has been the new issue volume. The headline statistic of €71 billion of leveraged loan issuance is encouraging, but a relatively high percentage of this was re-pricings and re-financings, with circa 31% of the Index re-pricing over the year. Given the strong demand for the European loan asset class and the amount of Private Equity dry powder, we are cautiously optimistic that new issue volumes will improve in 2017.

§ The new issue supply will have a direct impact on spreads, which tightened in over the last quarter

§ New issue spreads were actually lower in Europe than the US in Q4 2016, but when you include the benefit of average floors, effective spreads remained c.50bps better in Europe as 3 month US LIBOR recently hit 1% (through the value of the average floor).

§ Interest rates are forecast to rise globally over the next five years, with US rates forecast to rise first.

§ Alcentra do not currently intend to allocate to US loans. As a reminder, UK based loan funds with a GBP NAV will not benefit from a US rate rise if they buy USD denominated loans. Currency hedging removes the effect of a rate rise in any currency other than GBP.

§ Equally, negative European rates do not harm the Fund's performance. Again, currencies are hedged plus the underlying EUR assets will typically have a return pick-up from interest rate floors.

 

5S&P LCD Global View, 31 March 2017;

6Defaults as a % principal value;.

7S&P Index Data, 30 November 2016; Large corporates, data reflects rolling 3 months

 

Alcentra Limited

27 June 2017

 

Director's Report

 

The Directors present the Annual Report and Audited Financial Statements of the Company for the year ended 31 March 2017.

 

Board of Directors

The Directors of the Company who served during the year and their biographies are detailed below.

 

Directors' Interests

None of the Directors had a material interest in any contract, which is significant to the Company's business. Ian Fitzgerald, Jonathan Bridel and Anne Ewing each held a minor interest in the Company's share capital during the year ended 31 March 2017 as follows:

 

Director

Number of Shares

Ian Fitzgerald

15,000

Jonathan Bridel

5,000

Anne Ewing

5,000

 

There have been no changes in the interests of the Directors since the year-end.

 

Statement of Disclosure of Information to the Auditor

The Directors who held office at the date of approval of this Directors' Report confirm that, so far as they are each aware, there is no relevant audit information of which the Company's auditor is unaware and that they have taken the steps that they ought to have taken as Directors to make themselves aware of any relevant audit information and to establish that the Company's auditor is aware of that information.

 

Internal Controls and Risk Management

The Risk Committee has established a process for identifying, evaluating and managing any major risks faced by the Company. The process is subject to regular review by the Board and accords with the AIC Code.

 

The Risk Committee is responsible in ensuring that all risks affecting the Company are identified through a robust assessment and that a policy is implemented to mitigate, monitor and manage these risks which should include:

 

· Market risk;

· Liquidity risk;

· Counterparty risk;

· Operational risk; and

· Conflicts of interest.

The Board is responsible overall for the Company's system of internal control and for reviewing its effectiveness. However, such a system is designed to manage rather than eliminate risks of failure to achieve the Company's business objectives and can only provide reasonable and not absolute assurance against material misstatement or loss.

 

The Board receives reports from the Investment Manager on the Company's risk evaluation process and reviews changes to key risks identified. The Board has undertaken a full review of the Company's business risks, which have been analysed and recorded in a risk report, which is reviewed and updated regularly. Each quarter the Board receives a formal report from the Investment Manager which details the steps taken to monitor the areas of risk including those that are not directly the responsibility of the Investment Manager and which reports the details of any known internal control failures. The Board receives each year from the Administrator a report on its internal controls which includes a report from the Administrator's auditor on the control policies and procedures in operation.

 

The Investment Manager has established an internal control framework to provide reasonable but not absolute assurance on the effectiveness of the internal controls operated on behalf of its clients. The effectiveness of the internal controls is assessed by the Investment Manager's compliance and risk department on an on-going basis. The Investment Manager's controls processes have also been outlined to the Board.

 

The Management Engagement Committee conducted a review of the Investment Manager, the Administrator and the Custodian during the year ended 31 March 2017 and had concluded that the performance of all had been satisfactory and no internal control issues were noted.

 

The Board's assessment of the Company's key risks and uncertainties is set out in the Executive Summary.

 

By means of the procedures set out above, the Board confirms that it has reviewed the effectiveness of the Company's system of internal controls for the year ended 31 March 2017 and to the date of approval of this Annual Report and that no issues have been noted.

 

Share Capital

The share capital of the Company consists of an unlimited number of shares which upon issue the Directors may classify as Ordinary Shares, B Shares, or C Shares of such classes denominated in such currencies as the Directors may determine.

 

Notifications of Shareholdings

The Company had been notified in accordance with Chapter 5 of the DTR (which covers the acquisition and disposal of major shareholdings and voting rights), of the following shareholders that had an interest of greater than 5% in the Company's issued share capital.

 

31 March 2017

Number of voting rights

Percentage of total voting rights (%)

The Bank of New York Mellon Corporation

28,156,800

13.83

Old Mutual Plc

20,400,584

10.02

Sarasin & Partners LLP

17,905,745

8.8

FIL Limited

10,449,911

5.13

 

Between 1 April 2017 and 27 June 2017, the following notifications were received:

 

Number of voting rights

Percentage of total voting rights (%)

CCLA Investment Management Ltd

10,058,000

5.71

Courtiers Asset Management Limited

10,424,575

5.00

Old Mutual Plc

17,810,074

8.81

 

Borrowing Limits

The Company does not and will not utilise leverage to achieve its investment objective, save that it is anticipated that the Company may seek access to a revolving credit facility to allow it to take advantage of opportunities to purchase whole portfolios of assets should these become available. Any such borrowing would be intended to be short term until such time as it could be repaid through the issuance by the Company of new shares and will at all times be subject to a maximum leverage level equal to 20% of the Company's NAV at the time of drawdown of any such borrowing.

 

There were no borrowings as at 31 March 2017 (31 March 2016: £nil)

 

Global Greenhouse Gas Emissions

The Company has no greenhouse gas emissions to report from its operations for the year to 31 March 2017, nor does it have responsibility for any other emission-producing sources. 

 

Independent Auditor

KPMG Channel Islands Limited ("KPMG"), has indicated its willingness to continue in office as auditor and a resolution proposing its re-appointment and to authorise the Directors to determine its remuneration will be proposed at the forthcoming AGM.

 

Events After the Reporting Date

The Directors are not aware of any developments that might have a significant effect on the operations of the Company in subsequent financial periods that are not already disclosed in this report or the attached audited financial statements.

 

Please refer to note 15 for details on events after the reporting date.

 

For and on behalf of the Board

 

Ian Fitzgerald

Chairman

 

27 June 2017

 

Directors' Biographies

 

Ian Fitzgerald (Non-Executive Chairman, Chairman of the Management Engagement Committee and Chairman of the Risk Committee)

Ian is currently a Director and Chief Executive Officer of Loans Specialist Advisory Services Limited, a company established to provide specialist loan product business services. Ian held senior management positions within Lloyds Bank Capital Markets from 1997 to 2011. From 2004 he was managing Director and Head of Loan Markets, responsible for the bank's primary and secondary loan market businesses globally, including all corporate, acquisition, leveraged, project, infrastructure and property-related loan finance.

 

Ian joined Lloyds from Hill Samuel as Head of Loan Syndication and Distribution, upon Lloyds' merger with Hill Samuel TSB Bank plc in 1997. Prior to joining Hill Samuel in 1992, Ian held senior lending and syndicate roles at Chemical Bank, Manufacturers Hanover Limited, Bankers Trust International Limited, and other financial institutions. Ian commenced his banking career with Barclays Bank International in 1975. Ian was chairman of the Loan Market Association (''LMA'') from 2009 to 2011, having been appointed as a non-executive Director of the LMA in 2006.

 

Jonathan Bridel (Non-Executive Director and Chairman of the Audit Committee)

Jonathan is a Guernsey resident and is currently a non-Executive Director of the Renewables Infrastructure Group Limited (FTSE 250), Starwood European Real Estate Finance Limited, Funding Circle SME Income Fund Limited and Sequoia Economic Infrastructure Income Fund Limited which are listed on the Main Market of the London Stock Exchange. Other companies for which Jonathan acts as a Director include DP Aircraft I Limited and Fair Oaks Income Fund Limited. Jonathan was previously Managing Director of Royal Bank of Canada's investment businesses in the Channel Islands and served as a Director on other RBC companies including RBC Regent Fund Managers Limited. Prior to joining RBC, Jonathan served in a number of senior management positions in banking, specialising in credit and corporate finance and private businesses as Chief Financial Officer in London, Australia and Guernsey having previously worked at Price Waterhouse Corporate Finance in London.

 

Jonathan graduated from the University of Durham with a degree of Master of Business Administration, holds qualifications from the Institute of Chartered Accountants in England and Wales (1987) where he is a Fellow, the Chartered Institute of Marketing and the Australian Institute of Company Directors. Jonathan is a Chartered Marketer and a member of the Chartered Institute of Marketing and the Institute of Directors and a Chartered Fellow of the Chartered Institute for Securities and Investment.

 

Anne Ewing (Non-Executive Senior Independent Director, Chairman of the Remuneration and Nomination Committee)

Anne serves as a Non-Executive Director of Global Mena Financial Assets Limited, CDC Holdings Limited, Kleinwort Benson Bank Limited, Kleinwort Benson Bank (CI) Limited and Silverfleet Capital (Guernsey) Limited, SG Hambros Bank (Channel Islands) Limited, SG Hambros Trust Company (Channel Islands) Limited, Silverfleet Capital II (Guernsey) Limited and Clareant Structured Credit Opportunities Fund III. Anne was previously an Executive Director and Licensee of Imperium Trust Company Limited and has held senior positions with Dexion Capital (Guernsey) Limited, Dominion Fund Management Limited, KPMG Channel Islands Limited, Rothschild Bank CI Limited and Asset Management, Old Mutual and Citibank NA.

 

Anne holds an ACCA Certified Diploma in Accounting & Finance, graduated from Bournemouth University with Masters of Science Degree in Corporate Governance & Administration/Grad ICSA, is a Chartered Fellow of the Chartered Institute of Securities & Investment, a Fellow of the Institute of Chartered Secretaries and Administrators, an Associate Member of the Association of Corporate Treasurers, a Member of the Institute of Directors and past Guernsey Branch Chairman. Anne is a member of the Guernsey Investment Fund Association and is a PRA/FCA Approved Person under the Senior Manager Regime SMF12 and SMF13.

 

Corporate Governance Report

 

Introduction

The Board is committed to high standards of corporate governance and has put in place a framework for corporate governance which it believes is appropriate for the Company.

 

Applicable Corporate Governance Codes

The AIC Code requires listed companies to disclose how they have applied the principles and complied with the provisions of the UK Corporate Governance Code (UK Code) as issued by the Financial Reporting Council ("FRC"). It provides specific corporate governance guidelines to investment companies.

 

The Board considers that reporting against the principles and recommendations of the AIC Code and by reference to the AIC Guide (which incorporates the UK Code), will enable shareholders to make a comprehensive assessment of the Company's governance principles.

 

The FRC has confirmed that AIC member companies who report against the AIC Code and who follow the AIC Guide will be meeting obligations in relation to the UK Code, paragraph 9.8.6 of the Listing Rules and associated disclosure requirements of the DTR.

 

Copies of the AIC Code, the AIC Guide and the UK Code can be found on the respective organisations' web sites www.theaic.co.uk and www.frc.org.uk.

 

 

Corporate Governance Statement

The AIC Code comprises 21 principles and the Directors believe that during the year under review they have complied with all the recommendations of the AIC Code and the relevant provisions of the UK Code insofar as they apply to the Company's business except as set out below:

 

· the role of the chief executive;

· executive Directors' remuneration; and

· internal audit function.

 

For the reasons set out in the AIC Guide, and as explained in the UK Code, the Board considers these provisions are not relevant to the position of the Company, being an externally managed investment company. In particular, all of the Company's day-to-day management and administrative functions are outsourced to third parties. As a result, the Company has no executive Directors, employees or internal operations. The Company has therefore not reported further in respect of these provisions.

 

The Company complies with the corporate governance statement requirements pursuant to the DTR by virtue of the information included in the Corporate Governance section of the Annual Report together with information contained in the Strategic Report and Directors' Report.

 

The Board, Independence and Composition

The Board consists of three Directors, all of whom are independent of the Investment Manager and demonstrate a breadth of investment, accounting and professional experience. The Directors are listed on above along with a biography of each Director, demonstrating their professional knowledge and experience. Jonathan Bridel and Anne Ewing are resident in Guernsey, Ian Fitzgerald is resident in the UK.

 

The Board considers that all the Directors have different qualities and areas of expertise on which they may lead where issues arise and to whom concerns can be conveyed. The balance and independence of our Board is kept under review by the Remuneration and Nomination Committee, details of which can be found on below.

 

The Directors consider that there are no factors, as set out in principle 1 or 2 of the AIC Code, which compromise the Chairman's or other Directors' independence and that they all contribute to the affairs of the Company in an adequate manner. The Board reviews the independence of all Directors annually.

 

Anne Ewing was appointed as a Senior Independent Director with effect from 1 December 2015, which put in place an agreed protocol that Anne Ewing would act as chairman if the Chairman was unable to attend a Board meeting.

 

During the year ended 31 March 2017, Anne Ewing was appointed as a director of an investment company which is also managed by the Investment Manager. The Board have discussed Anne Ewing's independence with regard to the AIC's guidance on this matter and concluded that Anne Ewing is independent.

The Board believe that Anne Ewing's relationship with the Investment Manager, (as a result of being appointed as a director of an investment company which is also managed by the Investment Manager), would not affect her judgement in respect of her duties as a Senior Independent Director, Chairman of the Remuneration and Nomination Committee or Chairman of the Management Engagement Committee. In order to promote the efficient and effective distribution of workloads amongst the Directors, and taking into account the Management Engagement Committee's function to review the performance of the Investment Manager, the Board have concluded that Ian Fitzgerald should be appointed as chairman of the Management Engagement Committee with Anne Ewing remaining as a member. With effect from 27 June 2017, Ian Fitzgerald was appointed as the Chairman of the Management Engagement Committee.

Directors' Duties and Responsibilities

The Chairman's responsibilities include the leadership, operation and governance of the Board, ensuring effectiveness, and setting the agenda for the Board.

 

The Board meets at least four times each year and deals with the important aspects of the Company's affairs including the setting and monitoring of investment strategy and the review of investment performance. The Investment Manager takes decisions as to the purchase and sale of individual investments, in line with the investment policy and strategy set by the Board. The Investment Manager, together with the Company Secretary, also ensures that all Directors receive all relevant management, regulatory and financial information relating to the Company and its Portfolio of investments in a timely manner. Representatives of the Investment Manager attend each Board meeting, enabling Directors to question any matters of concern or seek clarification on certain issues. Matters specifically reserved for decision by the full Board have been defined and a procedure adopted for Directors in the furtherance of their duties to take independent professional advice at the expense of the Company.

 

The Company Secretary acts as Secretary to the Board and Committees and in doing so it:

 

· assists the Chairman in ensuring that all Directors have full and timely access to all relevant documentation;

· organises induction of new Directors; and

· is responsible for ensuring that the correct Board procedures are followed and advises the Board on corporate governance matters.

 

Board and Committees

The Board has established four committees: the Audit Committee, the Management Engagement Committee, the Remuneration and Nomination Committee and the Risk Committee. Each committee membership comprises all Directors and operate within clearly defined terms of reference and duties. The terms of reference for each committee are available on the Company's website: www.aefrif.com.

 

Audit Committee

The Audit Committee is responsible for the provision of effective governance over the appropriateness of the Company's financial reporting including the adequacy of related disclosures, the performance of the external auditor and the management of the Company's systems of internal controls and business risks. Meetings of the Audit Committee are to be held at least three times a year at appropriate times in the reporting and audit cycle and otherwise as required.

 

The report on the role and activities of the Audit Committee and its relationship with the external auditor is set out in the Audit Committee Report.

 

Remuneration and Nomination Committee

The Remuneration and Nomination Committee is responsible for ensuring that the Board comprises individuals with the necessary skills, knowledge and experience to ensure that it is effective in discharging its responsibilities and oversight of all matters relating to corporate governance and to review the on-going appropriateness and relevance of the remuneration policy.

 

Performance Evaluation

The Remuneration and Nomination Committee undertakes an evaluation of the Board on an annual basis. The performance of each Director is considered as part of a formal review by the Remuneration and Nomination Committee. The Directors also meet without the Chairman present in order to review his performance.

 

The Committee reviewed the performance of the Chairman in his role and agreed that Mr Fitzgerald was very experienced and his performance and leadership were an asset to the Company. The Chairman also reviews each individual Director's contribution.

 

As a result of the recommendations made in this year's Board performance evaluation, the Board has agreed:

 

· that all Directors are considered independent; and

· all Directors should be proposed for reappointment at the 2017 AGM and anually thereafter.

 

The Remuneration and Nomination Committee considers that while the Board is small in number, it is very well balanced, works well together and has diversity through thought, experience, skills, qualifications, gender and age.

 

It is intended that the Board shall, at least once every three years, engage a third-party to perform an external review of the Board's performance. An external evaluation of the Board was undertaken by Optimus Group Limited ("Optimus") during the year ended 31 March 2016 (the "External Board Evaluation Report"). The next external review will be undertaken in 2019. An internal review was undertaken during the year ended 31 March 2017. There were no significant findings noted.

 

Management Engagement Committee

The Management Engagement Committee is responsible for reviewing the performance of all service providers (including the Investment Manager).

 

The Board reviews the performance of the Company's third-party service providers together with their anti-bribery and corruption policies to ensure that they comply with the Bribery Act 2010 and the Prevention of Corruption (Bailiwick of Guernsey) Law 2003, and ensure their continued competitiveness and effectiveness.

 

As part of the Board's ongoing evaluation of third party service providers, it considers and reviews on a periodic basis contractual arrangements with the major service providers of the Company. A review of the major service providers was conducted on 31 January 2017 and the Committee had concluded the performance of all the providers had been satisfactory.

 

The Committee also performs periodic reviews of the Investment Manager's procedures for undertaking investment decisions to ensure decisions are consistent with the approved investment policy and strategies of the Company.

 

The Directors have adopted a procedure whereby they are required to report any potential acts of bribery and corruption in respect of the Company to the Company's Compliance Officer.

 

Risk Committee

The main roles of the Risk Committee are identifying and assessing the key risks and uncertainties facing the Company, recording and monitoring the position of such risks on a periodic basis and assessing any mitigating factors of such risks and the controls implemented by the Risk Committee to mitigate such risks. This analysis is performed as part of the Business Risk Assessment.

 

The key risks and uncertainties facing the Company that the Board have identified are detailed in the Executive Summary.

 

The Risk Committee is also responsible for the oversight of the operational activity including working capital, corporate governance of the Company and monitoring the regulatory requirements applicable to the Company under the Alternative Investment Fund Manager Directive ("AIFMD"). The Committee will also examine the valuation of the Company investments periodically throughout the year.

 

Attendance at scheduled meetings of the Board and its committees for the year ended 31 March 2017

 

Board

Audit Committee

Management Engagement Committee

Remuneration and Nomination Committee

Risk Committee

Number of meetings during the year

8

5

1

1

5

Ian Fitzgerald 1

5

5

1

1

5

Anne Ewing

8

5

1

1

5

Jonathan Bridel

8

5

1

1

5

 

1 Ian Fitzgerald is resident in the UK and prevented by the Company's Articles of Incorporation from attending Board meetings from the UK. He attends all quarterly Board meetings, but it is not deemed cost-effective for the Company for him to travel to Guernsey for the regular meetings to approve dividends in line with the Company's dividend policy.

 

The Committees report to the Board as part of a separate agenda item, on the activity of the Committee and matters of particular relevance to the Board in the conduct of their work.

 

In addition to the four quarterly Board meetings, an additional full Board meeting and three ad-hoc Board meetings were held during the year for various matters.

 

Directors unable to attend a Board meeting are provided with the board papers and can discuss issues arising in the meeting with the Chairman or another non-executive Director.

 

Directors' Appointment, Retirement and Rotation

The Articles of Incorporation require that all Directors submit themselves for election by shareholders at the first opportunity following their appointment and shall not remain in office longer than three years since their last election or re-election without submitting themselves for re-election. The AIC guide states that all non-executive Directors should be submitted for re-election by shareholders at regular intervals and that nomination for re-election should not be assumed but be based on disclosed procedures and continued satisfactory performance. 

 

All Directors will stand for re-election at the AGM on 20 September 2017 and annually thereafter.

 

No Director has a service contract with the Company. Directors have agreed letters of appointment with the Company, copies of which are available for review by shareholders at the Registered Office and will be available at the AGM. Any Director may resign in writing to the Board at any time by proving the required notice.

 

Tenure of Non-Executive Directors

The Board has adopted a policy on tenure that is considered appropriate for an investment company. The Board considers that length of service does not, by itself, lead to a closer relationship with the Investment Manager or necessarily affects a Directors' independence.

 

The Board's tenure policy seeks to ensure that the Board is well balanced and will be refreshed from time to time by the appointment of new Directors with the skills and experience necessary to replace those lost by Directors' retirements or to complement those of the existing Directors. The achievement of a sensible balance is the most important objective for the Board. Directors must be able to demonstrate their commitment to the Company. The Board seeks to encompass relevant past and current experience of various areas relevant to the Company's business. The Board will further consider succession planning and the possibility of appointing an additional Director to aid succession planning as the Company grows.

 

Date first elected by shareholders

Date last elected by shareholders

Years from last election to 2017 AGM

Ian Fitzgerald

November 2012

September 2014

3

Jonathan Bridel

November 2012

September 2015

2

Anne Ewing

November 2012

September 2016

1

 

Conflict of Interests

The Directors have a duty to avoid situations where they have, or could have, a direct or indirect interest that conflicts, or possibly could conflict, with the Company's interests. Directors are required to disclose all actual and potential conflicts of interest to the Chairman in advance of any proposed external appointment. Only Directors who have no material interest in the matter being considered will be able to participate in the Board approval process. In deciding whether to approve an individual Director's participation, the other Directors will act in a way they consider to be in good faith in assessing the materiality of the conflict in accordance with the Company's Articles of Incorporation.

 

The Board believes that its powers of authorisation of conflicts of interest have operated effectively. The Board also confirms that its procedure for the approval of conflicts of interest has been followed by the Directors.

 

Board Diversity

The Board supports the recommendations of the Davies Report and believes in and values the importance of diversity, including gender, to the effective functioning of the Board.

 

However, the Board does not consider it appropriate or in the interest of the Company and its shareholders to set prescriptive targets for gender or nationality on the Board. Any future appointments would be primarily based on merit of skills, experience and knowledge.

 

Induction/Information and Professional Development

Directors are provided, on a regular basis, with key information on the Company's policies, regulatory requirements and its internal controls. Regulatory and legislative changes affecting Directors' responsibilities are advised to the Board as they arise along with changes to best practice from, amongst others, the company secretary and the auditor. Advisers to the Company also prepare reports for the Board from time to time on relevant topics and issues. In addition, Directors attend relevant seminars and events to allow them to continually refresh their skills and knowledge and monitor changes within the investment industry. The Chairman reviewed the training and development needs of each Director during the annual Board evaluation process. The Chairman confirmed that all Directors actively kept up to date with industry developments and issues. Seminars and events attended include those provided by the AIC.

 

When a new Director is appointed to the Board, they will be provided with all relevant information regarding the Company and their duties and responsibilities as a Director. In addition, a new Director will also spend time with representatives of the Investment Manager in order to learn more about their processes and procedures.

 

Director's Remuneration and Annual Evaluation of the Board and that of its Audit Committee and Individual Directors

The Remuneration and Nomination Committee periodically reviews the fees paid to the Directors and compares these with the fees paid by listed companies generally.

 

An annual evaluation of the Board, the Remuneration and Nomination Committee and Directors is undertaken considering the balance of skills, experience, independence and knowledge, its diversity, including gender, how the Board works together as a unit, and other factors relevant to its effectiveness.

 

It is intended that the Board shall, at least once every three years, engage a third-party to perform an external review of the Board's performance, constitution and terms of reference to ensure that it is operating effectively and to recommend any changes it considers necessary. Refer to above for the internal review performed during the year.

 

There was no change to the Director's remuneration during the year ended 31 March 2017.

 

Details of the remuneration arrangements for the Board and Audit Committee can be found in the Directors' Remuneration Report.

 

Independent Advice

The Board recognises that there may be occasions when one or more of the Directors feels it is necessary to take independent legal advice at the Company's expense. A procedure has been adopted to enable them to do so, which is managed by the Company Secretary.

 

Indemnities

To the extent permitted by the Companies Law, the Company's Articles of Incorporation provide an indemnity for the Directors against any liability except such (if any) as they shall incur by or through their own breach of trust, breach of duty or negligence.

 

During the year, the Company has maintained insurance cover for its Directors and Officers under a Directors' and Officers' liability insurance policy.

 

Relationship with the Investment Manager and the Administrator

The Board has delegated various duties to external parties including the management of the investment portfolio, the custodial services (including the safeguarding of assets), the registration services and the day-to-day company secretarial, administration and accounting services. Each of these contracts was entered into after full and proper consideration by the Board of the quality and cost of services offered, including the control systems in operation in so far as they relate to the affairs of the Company.

 

The Board receives and considers reports regularly from the Investment Manager and ad hoc reports and information are supplied to the Board as required. The Investment Manager takes decisions as to the purchase and sale of individual investments. The Investment Manager complies with the risk limits as determined by the Board and has systems in place, including stress testing, to monitor the liquidity risk of the Company. The Investment Manager and Administrator also ensure that all Directors receive, in a timely manner, all relevant management, regulatory and financial information. Representatives of the Investment Manager and Administrator attend each Board meeting enabling the Directors to probe further on matters of concern.

 

A formal schedule of matters specifically reserved for decision by the full Board has been defined and a procedure adopted for Directors, in the furtherance of their duties, to take independent professional advice at the expense of the Company within certain parameters. The Directors have access to the company secretary who is responsible to the Board for ensuring that Board procedures are followed and that applicable rules and regulations are complied with. The Board, the Investment Manager and the Administrator operate in a supportive, co-operative and open environment.

 

Continued Appointment of the Investment Manager

The Board reviews investment performance at each Board meeting and a formal review of all service providers is conducted annually by the Management Engagement Committee. As a result of the review it is the opinion of the Directors that the continued appointment of the current Investment Manager on the terms agreed is in the interest of the Company's shareholders as a whole.

 

The Investment Manager has extensive investment management resources and wide experience in managing investment companies.

 

Shareholder Engagement

The Board believes that the maintenance of good relations with shareholders is important for the long-term prospects of the Company. It has, since admission, offered to engage with investors and liaises closely with the Company's corporate broker in this respect. Where appropriate the Chairman and other Directors are available for discussion about governance and strategy with major shareholders and the Chairman ensures communication of shareholders' views to the Board. The Board receives feedback on the views of shareholders from its corporate broker and the Investment Manager, and shareholders are welcome to contact the Directors at any time via the Company Secretary.

 

The Board believes that the AGM provides an appropriate forum for investors to communicate with the Board, and encourages participation. The AGM is attended by the Directors. There is an opportunity for individual shareholders to question the Chairman of the Board, the Audit Committee, the Management Engagement Committee, Risk Committee and the Remuneration and Nomination Committee at the AGM. Details of proxy votes received in respect of each resolution will be made available to shareholders at the meeting and will be posted on the Company's website following the meeting.

 

The Annual and Interim Reports and a monthly fact sheet are available to provide shareholders with a clear understanding of the Company's activities and its results. This information is supplemented by the daily calculation and publication on the London Stock Exchange of the NAV of the Company's Shares. All documents issued by the Company can be viewed on the website: www.aefrif.com.

 

2017 AGM

The 2017 AGM will be held in Guernsey on 20 September 2017 at 11:00 BST. The notice for the AGM sets out the ordinary and special resolutions to be proposed at the meeting. Separate resolutions are proposed for each substantive issue.

 

It is the intention of the Board that the Notice of AGM be issued to shareholders so as to provide at least twenty working days' notice of the meeting. Shareholders wishing to lodge questions in advance of the meeting and specifically related to the resolutions proposed are invited to do so by writing to the Company Secretary at the address given on below. At other times the Company Secretary responds to letters from shareholders on a range of issues.

 

Voting on all resolutions at the AGM is by poll. The proxy votes cast, including details of votes withheld, are disclosed to those in attendance at the meeting and the results are published on our website and announced via the RNS.

 

AIFMD 

AIFMD seeks to regulate alternative investment fund managers ("AIFM") and imposes obligations on managers who manage alternative investment funds ("AIF") in the EU or who market shares in such funds to EU investors. The Company is categorised as a self-managed Non EEA AIF for the purposes of the AIFM Directive. In order to maintain compliance with the AIFM Directive, the Company needs to comply with various organisational, operational and transparency obligations.

 

The Company has registered with the UK FCA, under the relevant national private placement regime.

 

This Corporate Governance Report was approved by the Board of Directors on 27 June 2017 and signed on its behalf by:

 

Ian Fitzgerald Jonathan Bridel

Chairman Audit Committee Chairman

 

Audit Committee Report

 

The Audit Committee comprises all of the Directors. All of the Audit Committee's members have recent and relevant financial experience. The Chairman of the Audit Committee, Jonathan Bridel, is a Fellow of the Institute of Chartered Accountants in England and Wales and in addition serves as chairman of the audit committee for some other listed investment companies. Previously Jonathon worked in senior positions in investment, corporate finance and credit and was Chief Financial Officer of two private multinational businesses. The Board is satisfied that Jonathan has recent and relevant financial experience, as required under the UK Corporate Governance Code. The qualifications of the members of the Audit Committee are outlined in Director's Biographies and can be found above.

 

Role of the Audit Committee

The main roles and responsibilities of the Audit Committee are the provision of effective governance over the appropriateness of the Company's financial reporting including the adequacy of related disclosures, the performance of the external auditor and the management of the Company's systems of internal controls and business risks.

 

The Audit Committee's main functions are:

 

· reviewing the Company's financial results announcements and audited financial statements and monitoring compliance with relevant statutory and listing requirements;

· reporting to the Board on the appropriateness of the Company's accounting policies and practices including critical accounting policies and practices;

· advising the Board on whether the Committee believes the Annual Report and financial statements, taken as a whole, is fair, balanced and understandable and provides the information necessary for shareholders to assess the Company's performance, business model and strategy;

· agreeing with the auditor the external audit plan including discussions on the key risk areas within the audited financial statements;

· overseeing the relationship with and appointment of the external auditor;

· considering the financial and other implications on the independence of the auditor arising from any non-audit services to be provided by the auditor;

· considering the appropriateness of appointing the auditor for non-audit services;

· scrutiny of the investment valuations, and

· compiling a report on its activities to be included in the Company's Annual Report.

 

Internal Controls

The Audit Committee is responsible for reviewing the effectiveness and internal control policies and procedures over financial reporting and identification, assessment and reporting of risk. The Directors have reviewed the BNP Paribas Securities Services ISAE 3402 Report for the period from 1 October 2015 to 30 September 2016 (on the description of controls placed in operation, their design and operating effectiveness) on Fund Administration and Middle Office Outsourcing, and are pleased to note that no significant issues were identified.

 

In accordance with the FRC's Internal Control: Guidance to Directors, and the FRC's Guidance on Audit Committees, the Board confirms that there is an on-going process for identifying, evaluating and managing the significant internal control risks faced by the Company.

 

As the Company does not have any employees it does not have a "whistleblowing" policy in place, however the Board has reviewed the whistleblowing procedures of the Investment Manager with and have noted no issues. The Company delegates its main administrative functions to third-party providers who report on their policies and procedures to the Board. Key service providers have the option to contact the Audit Chairman directly if they have any issues.

 

The Board believes that as the Company delegates its day-to-day administrative operations to third-parties (which are monitored by the Board), it does not require an internal audit function.

 

Committee Meetings

The Committee meets formally at least three times a year. Only members of the Audit Committee have the right to attend Audit Committee meetings. However, other Directors and representatives of the Investment Manager and Administrator will be invited to attend Audit Committee meetings on a regular basis and other non-members may be invited to attend all or part of the meeting as and when appropriate and necessary. The Company's external auditor, KPMG is also invited to each meeting.

 

In the year ended 31 March 2017, the Audit Committee met on five occasions and the members' attendance record can be found above.

 

Significant Risks in Relation to the Audited Financial Statements

In relation to the Annual Report and Audited Financial Statements for the year ended 31 March 2017, the Audit Committee views the valuation of Company's investments as a significant risk.

 

The Company's investment is the Profit Participating Bonds held in the Subsidiary, which are designated as fair value through profit or loss. The fair value of the Profit Participating Bonds are based on the NAV of the Subsidiary, which has been prepared in accordance with International Financial Reporting Standards as adopted by the European Union ("IFRS") and applicable law.

 

The Audit Committee confirms that the Risk Committee continues to examine the valuation of the Company's investment and the underlying investments held in the Subsidiary periodically throughout the year. Additionally, as in prior years, the Audit Committee as part of its annual audit procedures visited the Investment Manager to discuss and review the valuation methodology of the Subsidiary's investments, internal controls and operations used by the Investment Manager. This meeting allowed the Audit Committee to gain assurances as to the appropriateness and robustness of the valuation methodology applied by the Investment Manager. The Audit Committee Chairman also visited and reviewed the administration and custody operations of BNP in Luxembourg during the year and the Management Engagement Committee Chairman reviewed operations in Jersey.

 

The Committee regularly reviews the valuations prepared by the Investment Manager for the Subsidiary's investments where readily available market prices are not available. The valuations of these investments are scrutinised and compared against valuations of investments with similar characteristics and are also subject to a sensitivity analysis based on changes in key assumptions. As at 31 March 2017, these represented 3.23% of total investments.

 

In addition to the above the Committee reviewed the quarterly pricing committee minutes and also considered KPMG's approach to its audit of the valuation in respect of the Company's investment and the Subsidiary's investments. The Committee discussed in depth with KPMG its approach to testing the appropriateness and robustness of the valuation methodology applied by the Investment Manager to the Subsidiary's investments. The members of the Committee had meetings with KPMG, where the audit findings were reported. KPMG did not report any significant differences between the valuations used by the Subsidiary and the work performed during the testing process.

 

Based on the above review and analysis, the Committee confirmed that they were satisfied with the valuation of the Subsidiary's investments and subsequently the Company's investment designated as fair value through profit or loss.

 

External Audit Process

The effectiveness of the external audit process is dependent on appropriate audit risk identification at the start of the audit cycle. The Committee received a detailed audit plan from KPMG, identifying their assessment of these key risks. For the year ended 31 March 2017, the primary risk identified was in relation to valuation of investments. The risk is tracked through the year and the Committee challenged the work done by KPMG to test management's assumptions and estimates around this area.

 

The Committee assessed the effectiveness of the audit process addressing these matters through the reporting received for both the interim and year-end financial statements. The Committee sought feedback from the Investment Manager and the Administrator on the effectiveness of the audit process.

 

Appointment and Independence

The Committee considers the reappointment of KPMG, including the rotation of the Audit Engagement Partner, and assesses its independence on an annual basis. KPMG is required under Ethical Standards to rotate the Audit Engagement Partner responsible for the Company audit every five years. The current Audit Engagement Partner, Dermot Dempsey, has overseen the audit of the Company for three audit cycles commencing in March 2015 following the retirement of his predecessor. KPMG has been the Company's auditor since the Company's listing in 2012.

 

The Committee reviews the objectivity and effectiveness of the audit process on an annual basis and considers the audit tendering provisions of the revised UK Code in determining whether the Company should put the audit engagement out to tender. The Company will put the audit services contract out to tender in 2020, or earlier if in the best interests of the Company. Having considered the quality and level of service currently being provided by KPMG, the Committee believes that it is in the best interests of the shareholders to retain its services and has therefore provided the Board with its recommendation to the shareholders on the reappointment of KPMG as external auditor for the year ending 31 March 2018.

 

Accordingly, a resolution proposing the reappointment of KPMG as the Company's auditor will be put to the shareholders at the AGM. There are no contractual obligations restricting the Committee's choice of external auditor.

 

Non Audit Services

To safeguard the objectivity and independence of the external auditor from becoming compromised, the Committee has a formal policy governing the engagement of the external auditor to provide non-audit services. No material changes have been made to this policy during the year. KPMG will only be appointed to provide non audit services if it is in the best interests of the Company. KPMG and the Directors have agreed that all non-audit services require the pre-approval of the Audit Committee prior to commencing any work. Fees for non-audit services are tabled annually so that the Audit Committee can consider the impact on auditor objectivity.

 

KPMG were remunerated as follows from 1 April 2016 to the date of approval of the audited financial statements:

 

£

Audit of the Company's financial statements

46,000

Interim Review of the Company's financial statements

15,000

Audit of the Subsidiary's financials statements

12,960

Total

73,960

 

During the year ended 31 March 2017, the only non-audit services provided by KPMG was the interim review, therefore the ratio of audit and audit related services to non-audit related services is 79%.

 

Committee Evaluation

The Committee's activities formed part of the Board evaluation performed in the year. Details of this process can be found under "Performance Evaluation".

 

Jonathan Bridel

Audit Committee Chairman

27 June 2017

 

Directors' Remuneration Report

 

Annual Remuneration Statement

This report meets the relevant rules of the Listing Rules and the AIC Code describes how the Board has applied the principles relating to Directors' remuneration. An ordinary resolution to ratify this report will be proposed at the AGM on 20 September 2017.

 

Changes to the Board

There were no changes to the Board during the year. All Directors will retire and stand for re-election annually.

 

Remuneration Summary

The Directors of the Company are remunerated per annum as follows:

 

· Chairman, Chairman of the Management Engagement Committee and Chairman of the Risk Committee - £50,000.

 

· Chairman of the Audit Committee - £42,000.

 

· Chairman of the Remuneration and Nomination Committee - £40,000.

 

The Company's policy is that Directors may receive a fee of £5,000 each for a C-share issue or similar placement programme.

 

Remuneration Policy

The determination of the Directors' fees is a matter dealt with by the Remuneration and Nomination Committee and the Board. The Committee considers the remuneration policy annually to ensure that it remains appropriately positioned. Directors will review the fees paid to the boards of directors of similar investment companies. No Director is to be involved in decisions relating to his or her own remuneration.

The Company's policy is for the Directors to be remunerated in the form of fees, payable quarterly in arrears. No Director has any entitlement to a pension, and the Company has not awarded any share options or long-term performance incentives to any of the Directors. No element of the Directors' remuneration is performance related.

 

Directors are authorised to claim reasonable expenses from the Company in relation to the performance of their duties.

 

The Company's policy is that the fees payable to the Directors should reflect the time spent by the Board on the Company's affairs and the responsibilities borne by the Directors and should be sufficient to enable high calibre candidates to be recruited. The policy is for the Chairman of the Board and Chairman of the Audit Committee to be paid a higher fee than the other Directors in recognition of their more onerous roles and more time spent. The Board may amend the level of remuneration paid within the limits of the Company's Articles of Incorporation.

 

Policy Table

Director's Fees Policy

Element

Operation of the Element

Maximum Potential Value

Performance Metrics Used for Fees

To recognise time spent and the responsibilities borne and to attract high calibre candidates who have the necessary experience and skills.

Director's fees are set by the Remuneration and Nomination Committee.

 

Annual fees are paid quarterly in arrears.

 

Fees are reviewed annually and against those for Directors in companies of similar scale and complexity.

 

Fees were last reviewed in January 2017.

 

Directors do not receive benefits and do not participate in any incentive or pension plans.

Current fee levels are shown in the section on implementation of policy.

 

The Company's Articles of Incorporation limit the aggregate fees payable to the Board of Directors to a total of £300,000 per annum.

Directors are not remunerated based on performance and are not eligible to participate in any performance related arrangements.

 

Service Contracts and Policy on Payment of Loss of Office

The Directors have agreed that they will stand for re-election annually. Any Director may resign in writing with six months' notice to the Board at any time. Directors' appointments are reviewed during the annual board evaluation.

 

No Director has a service contract with the Company. Directors have agreed letters of appointment with the Company.

 

All Directors will be put forward for re-election by shareholders at the AGM on 20 September 2017. The names and biographies of the Directors holding office at the date of this report are listed above.

 

Copies of the Director's letters of appointment are available for inspection by shareholders at the Company's registered office, and are available at the AGM. The dates of their letter of appointments and details of the outstanding term are shown below.

 

Dates of Directors' Letters of Appointment

Director

Date Appointed

Ian Fitzgerald

3 January 2012

Jonathan Bridel

3 November 2011

Anne Ewing

3 November 2011

 

Directors' Interests

The Company has not set any requirements or guidelines for Directors to own shares in the Company. Refer above for details on Directors' shareholdings in the Company.

 

Annual Report on Remuneration

The Company paid the following fees to the Directors for the year ended 31 March 2017.

 

Director

Fees

Other Fees1

Total

Ian Fitzgerald

59,515

-

59,515

Jonathan Bridel

49,933

-

49,933

Anne Ewing

47,537

-

47,537

Total

156,985

-

156,985

 

1 The Directors were not paid any other fees during the year.

 

No other remuneration or compensation was paid or is payable by the Company during the year to any of the Directors, other than travel expenses of €3,582.

 

Advisors to the Remuneration Committee

As noted, the Board employed the services of Optimus as external advisers in respect of its consideration of the Directors' remuneration. Optimus had confirmed in writing that Director remuneration remained appropriate, following the review conducted during the year ended 31 March 2016.

 

Anne Ewing

On behalf of the Nominations and Remuneration Committee

27 June 2017

 

Directors' Responsibilities Statement

 

The Directors are responsible for preparing the Directors' Report and the financial statements in accordance with applicable law and regulations. They are also responsible for ensuring that the Annual Report includes information required by the Listing Rules.

 

Guernsey company law requires the Directors to prepare financial statements for each financial year. Under that law they have elected to prepare the financial statements in accordance with IFRS.

 

The financial statements are required by law to give a true and fair view of the state of affairs of the Company for that period.

 

In preparing these financial statements, the Directors are required to:

 

· select suitable accounting policies and then apply them consistently;

· make judgements and estimates that are reasonable and prudent;

· state whether applicable accounting standards have been followed, subject to any material departures disclosed and explained in the audited financial statements; and

· prepare the financial statements on the going concern basis unless it is inappropriate to presume that the Company will continue in business.

 

The Directors are responsible for keeping proper accounting records, which disclose with reasonable accuracy at any time the financial position of the Company and to enable them to ensure that the financial statements comply with the Companies Law. They have a general responsibility for taking such steps as are reasonably open to them to safeguard the assets of the Company and to prevent and detect fraud and other irregularities.

 

The Directors are also responsible for ensuring that the Company complies with the Listing Rules and the DTR which, with regard to Corporate governance, requires the Company to disclose how it applied the principles and complied with the provisions of the UK Corporate Governance Code applicable to the Company.

 

The Directors confirm to the best of their knowledge that:

 

· the audited financial statements, which have been prepared in accordance with IFRS, give a true and fair view of the assets, liabilities, financial position and profit of the Company as at and for the year ended 31 March 2017;

 

· the Annual Report includes a fair review of the information required by DTR 4.1.8R (indication of important events up to 31 March 2017 and a description of key risks and uncertainties);

 

· the Annual Report includes a fair review of the information required by DTR 4.1.9R and 4.1.10R (analysis of the development and performance of the Company and position at year end aided by the use of key performance indicators; and where appropriate information relating to environmental factors);

 

· the Annual Report includes a fair review of the information required by DTR 4.1.11R (disclosure of important events that have occurred after the reporting date; future developments; financial risk management objectives and policies and Company exposure to price, credit, liquidity and cash flow risk); and

 

· the Annual Report and Audited Financial Statements, taken as a whole, are fair, balanced and understandable and includes a fair review of the development and performance of the business and position of the Company, together with a description of the key risks and uncertainties that the Company faces. This provides the information necessary for shareholders to assess the Company's performance, position, business model and strategy.

 

The Directors are also responsible for the maintenance and integrity of the corporate and financial information included on the Company's website.

 

Legislation in Guernsey governing the preparation and dissemination of audited financial statements may differ from legislation in other jurisdictions.

 

By order of the Board

 

Ian Fitzgerald Jonathan Bridel

Chairman Audit Committee Chairman

 

Independent Auditor's Report to the Members of Alcentra European Floating Rate Income Fund Limited

 

Opinions and conclusions arising from our audit

 

Opinion on financial statements

 

We have audited the financial statements of Alcentra European Floating Rate Income Fund Limited (the "Company") for the year ended 31 March 2017 which comprise the statement of comprehensive income, the statement of financial position, the statement of changes in shareholders' equity, the statement of cash flows and the related notes. The financial reporting framework that has been applied in their preparation is applicable law and International Financial Reporting Standards as adopted by the European Union ("EU"). In our opinion, the financial statements:

 

· give a true and fair view of the state of the Company's affairs as at 31 March 2017 and of its total comprehensive loss for the year ended 31 March 2017;

· have been properly prepared in accordance with International Financial Reporting Standards as adopted by the EU; and

· comply with the Companies (Guernsey) Law, 2008.

 

Emphasis of matter

 

In forming our conclusion on the financial statements, which is not modified, we have considered the adequacy of disclosures made in note 2 of the financial statements concerning the Directors' assessment of the use of the going concern assumption.

 

In line with the Company's Articles of Association, the Company is required to convene a general meeting to consider a Continuation Resolution every three years, with the next planned Continuation Resolution to be tabled at the Annual General Meeting on 20 September 2017. If the Continuation Resolution is not passed, the Directors shall put forward proposals to shareholders for the reconstruction or reorganisation of the Company.

 

The Company's Articles of Association require the Company to implement a Redemption Offer if, on average over the last twelve calendar months, the Company's shares have traded at a discount to net asset value in excess of 5% of the average net asset value per share. The Redemption Offer would require the Directors, subject to any legal or regulatory requirements, to offer each shareholder the opportunity to redeem up to 50% of their shareholding.

 

These requirements indicate the existence of material uncertainties which may cast a doubt about the Company's ability to continue as a going concern were either of these events to occur.

 

Our assessment of risks of material misstatement

 

The risks of material misstatement detailed in this section of this report are those risks that we have deemed, in our professional judgement, to have had the greatest effect on: the overall audit strategy; the allocation of resources in our audit; and directing the efforts of the engagement team. Our audit procedures relating to these risks were designed in the context of our audit of the financial statements as a whole. Our opinion on the financial statements is not modified with respect to any of these risks, and we do not express an opinion on these individual risks.

 

In arriving at our audit opinion above on the financial statements, the risk of material misstatement that had the greatest effect on our audit was as follows:

 

Valuation of investment in Subsidiary (€203,860,076 (equivalent to 98.44% of Net Asset Value))

 

Refer to the Audit Committee Report, Note 3.3 and Note 7 (financial instruments disclosures).

 

The risk - The Company's sole investment in Alcentra European Floating Rate Income S.A. (the "Subsidiary") is carried at fair value through profit or loss and represents a significant proportion of the Company's net assets. The carrying amount is calculated by assessing the fair value of the Subsidiary which reflects its net asset value incorporating the fair value of the Subsidiary's underlying portfolio of floating rate secured loans or high-yield bonds, which are predominantly rated below investment grade or deemed by the Investment Manager to be of a corresponding credit quality (the "Portfolio"). The Portfolio's carrying value is €202,478,555.

 

The Portfolio is valued using price quotes sourced from the Company's approved pricing providers which themselves are based on consensus prices received from third party broker quotes and market makers. Where price quotes are not available or are deemed to be unreliable, the Investment Manager's Investment Pricing Committee determines a price using valuation techniques including an assessment of comparable instruments taking into consideration the instrument's structural and credit characteristics.

 

The valuation of the Portfolio involves the application of valuation techniques which are judgemental. Consensus prices utilised may not represent prices traded in an active market. Where price quotes are determined in good faith by the Investment Manager, there is a risk of inappropriate selection and application of inputs and assumptions in determining the price. Consequently, the valuation of the Portfolio is considered to be a significant risk and area of audit focus.

 

Our response - Our audit procedures over the valuation of the Portfolio held by the Subsidiary included, but were not limited to the following:

 

· We tested the design and implementation of controls over the valuation of the Portfolio.

 

· We involved our own valuation specialist to support the challenge of the valuation of the Portfolio.

 

- For €35,817,824 of the Portfolio, our valuation specialist derived prices from independent data vendors, where available, and assessed the quality and integrity of these price quotes.

- Where price quotes from independent data vendors were not available, for €145,738,267 of the Portfolio, our valuation specialist derived an independent mark to model valuation based on market inputs for comparable instruments with similar structural and credit characteristics.

- For €16,061,900 of the Portfolio, our valuation specialist assessed the source of the external price quotes used by the Investment Manager and considered the reliability of that price as it relates to depth of price quotes.

 

· For the remaining €4,860,564 of the Portfolio we held discussions with the Investment Manager to understand the valuation approaches applied and where applicable we reviewed the Pricing Committee Approval Memorandums, reviewed available third party pricing information and reviewed the most recently available financial reporting prepared by the investee entities and considered by the Investment Manager in preparing the valuation

 

We also considered the Company's disclosures (see Note 3.1 (c)) in relation to the use of estimates and judgments in determining the fair value of investment in the Subsidiary and the Company's investment valuation policies adopted and fair value disclosures in Note 3.3 and Note 7 for compliance with International Financial Reporting Standards as adopted by the EU.

 

Our application of materiality and an overview of the scope of our audit

 

Materiality is a term used to describe the acceptable level of precision in financial statements. Auditing standards describe a misstatement or an omission as "material" if it could reasonably be expected to influence the economic decisions of users taken on the basis of the financial statements. The auditor has to apply judgment in identifying whether a misstatement or omission is material and to do so the auditor identifies a monetary amount as "materiality for the financial statements as a whole".

 

The materiality for the financial statements as a whole was set at €6,200,000. This has been calculated using a percentage of the Company's net asset value (of which it represents approximately 3%), which we believe is the most appropriate benchmark as net asset value is considered as the prime driver of return to the members.

 

We agreed with the audit committee to report to it all corrected and uncorrected misstatements we identified through our audit with a value in excess of €310,000, in addition to other audit misstatements below that threshold that we believe warranted reporting on qualitative grounds.

 

Our audit of the Company was undertaken to the materiality level specified above, which has informed our identification of significant risks of material misstatement and the associated audit procedures performed in those areas as detailed above. The audit was performed at the offices of BNP Paribas Securities Services S.C.A., Guernsey Branch.

 

Whilst the audit process is designed to provide reasonable assurance of identifying material misstatements or omissions it is not guaranteed to do so. Rather we plan the audit to determine the extent of testing needed to reduce to an appropriately low level the probability that the aggregate of uncorrected and undetected misstatements does not exceed materiality for the financial statements as a whole. This testing requires us to conduct significant depth of work on a broad range of assets, liabilities, income and expense as well as devoting significant time of the most experienced members of the audit team, in particular the Responsible Individual, to subjective areas of the accounting and reporting process.

 

An audit involves obtaining evidence about the amounts and disclosures in the financial statements sufficient to give reasonable assurance that the financial statements are free from material misstatement, whether caused by fraud or error. This includes an assessment of: whether the accounting policies are appropriate to the Company's circumstances and have been consistently applied and adequately disclosed; the reasonableness of significant accounting estimates made by the Board of Directors; and the overall presentation of the financial statements. In addition, we read all the financial and non-financial information in the Annual Report to identify material inconsistencies with the audited financial statements and to identify any information that is apparently materially incorrect based on, or materially inconsistent with, the knowledge acquired by us in the course of performing the audit. If we become aware of any apparent material misstatements or inconsistencies we consider the implications for our report.

 

Disclosures of principal risks

 

Based on the knowledge we acquired during our audit, we have nothing material to add or draw attention to in relation to:

 

· the directors' viability statement, concerning the principal risks, their management, and, based on that, the directors' assessment and expectations of the Company's continuing in operation over the five years to June 2022; or

· the disclosures in note 2 of the financial statements concerning the use of the going concern basis of accounting.

 

Matters on which we are required to report by exception

 

Under International Standards on Auditing ("ISAs") (UK and Ireland) we are required to report to you if, based on the knowledge we acquired during our audit, we have identified other information in the Annual Report that contains a material inconsistency with either that knowledge or the financial statements, a material misstatement of fact, or that is otherwise misleading.

 

In particular, we are required to report to you if:

 

· we have identified material inconsistencies between the knowledge we acquired during our audit and the directors' statement that they consider that the Annual Report and financial statements taken as a whole is fair, balanced and understandable and provides the information necessary for shareholders to assess the Company's performance, business model and strategy; or

· the Corporate Governance Report does not appropriately address matters communicated by us to the Audit Committee.

 

Under the Companies (Guernsey) Law, 2008, we are required to report to you if, in our opinion:

 

· the Company has not kept proper accounting records; or

· the financial statements are not in agreement with the accounting records; or

· we have not received all the information and explanations, which to the best of our knowledge and belief are necessary for the purpose of our audit.

 

Under the Listing Rules we are required to review the part of the Corporate Governance Report relating to the Company's compliance with the eleven provisions of the UK Corporate Governance Code specified for our review.

 

We have nothing to report in respect of the above responsibilities. Scope of report and responsibilities

 

The purpose of this report and restrictions on its use by persons other than the Company's members as a body

 

This report is made solely to the Company's members, as a body, in accordance with section 262 of the Companies (Guernsey) Law, 2008 and, in respect of any further matters on which we have agreed to report, on terms we have agreed with the Company. Our audit work has been undertaken so that we might state to the Company's members those matters we are required to state to them in an auditor's report and for no other purpose. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than the Company and the Company's members, as a body, for our audit work, for this report, or for the opinions we have formed.

 

Respective responsibilities of directors and auditor

 

As explained more fully in the Directors' Responsibilities Statement, the Directors are responsible for the preparation of the financial statements and for being satisfied that they give a true and fair view. Our responsibility is to audit, and express an opinion on, the financial statements in accordance with applicable law and ISAs (UK and Ireland). Those standards require us to comply with the UK Ethical Standards for Auditors.

 

Dermot A. Dempsey

For and on behalf of KPMG Channel Islands Limited

Chartered Accountants and Recognised Auditors

Glategny Court, Glategny Esplanade,

St Peter Port, Guernsey

GY1 1WR

27 June 2017

 

Statement of Comprehensive Income

For the year ended 31 March 2017

 

Notes

Year ended

31 March 2017

Year ended

31 March 2016

Income

Other income

77,398

-

Total income

77,398

-

Realised foreign exchange loss on forwards

(31,435,622)

(16,753,967)

Unrealised foreign exchange gain / (loss) on forwards

 

4,479,201

 

(2,442,639)

Foreign exchange gain / (loss)

11,749,410

(1,266,921)

Net gain on investment at fair value through profit or loss

 

7

 

13,973,386

 

8,737,367

Net realised and unrealised loss

(1,233,625)

(11,726,160)

 

Expenses

Investment management fees

4(a), 14

(1,508,430)

(1,760,929)

Directors' fees and travel expenses

14

(160,567)

(139,216)

Administration and professional fees

4(b)

(450,358)

(610,696)

Total operating expenses

(2,119,355)

(2,510,841)

Total comprehensive loss for the year

(3,275,582)

(14,237,001)

Basic and diluted loss per Ordinary Share (in Euro)

 

5

 

(1.8853)c

 

(8.0907)c

Basic and diluted loss per Ordinary Share (in Sterling)

 

5

 

(1.6080)p

 

(6.3977)p

 

All results are derived from continuing operations.

 

The accompanying notes form an integral part of these audited financial statements.

 

Statement of Financial Position

As at 31 March 2017

 

Notes

31 March 2017

31 March 2016

Non-current assets

Investment at fair value through profit or loss

7

203,860,076

229,376,731

Current assets

Cash and cash equivalents

1,107,637

1,785,849

Other receivables and prepayments

44,469

35,822

Derivative assets

7, 12

3,047,851

-

4,199,957

1,821,671

Total assets

208,060,033

231,198,402

Current liabilities

Other payables and accrued expenses

(963,565)

(460,451)

Derivative liabilities

7, 12

-

(1,431,350)

(963,565)

(1,891,801)

Net assets

207,096,468

229,306,601

Capital and reserves

Share capital

9

209,403,057

216,967,815

Retained earnings

(2,306,589)

12,338,786

Equity shareholders' funds

207,096,468

229,306,601

Number of Ordinary Shares

9

169,610,896

175,975,961

NAV per Ordinary Share - (in Sterling)

6

104.1435p

103.0379p

NAV per Ordinary Share (in Euro)

6

122.1009c

130.3056c

 

These audited financial statements were approved and authorised for issue by the Board of Directors on 27 June 2017, and signed on its behalf by:

 

Anne Ewing Jonathan Bridel

Director Director

 

The accompanying notes form an integral part of these audited financial statements.

 

Statement of Changes in Shareholders' Equity

For the year ended 31 March 2017

 

Share capital

Retained earnings

Total

Notes

Opening equity shareholders' funds at 1 April 2016

216,967,815

12,338,786

229,306,601

Total comprehensive loss for the year

-

(3,275,582)

(3,275,582)

Transactions with owners, recorded directly to equity

Dividends

10

-

(11,369,793)

(11,369,793)

Ordinary Shares repurchased and cancelled

9

(7,564,758)

-

(7,564,758)

Closing equity shareholders' funds at 31 March 2017

209,403,057

(2,306,589)

207,096,468

 

For the year ended 31 March 2016

 

Share capital

Retained earnings

Total

Notes

Opening equity shareholders' funds at 1 April 2015

216,243,415

39,418,467

255,661,882

Total comprehensive loss for the year

-

(14,237,001)

(14,237,001)

Transactions with owners, recorded directly to equity

Dividends

10

-

(12,842,680)

(12,842,680)

Proceeds from placing programme

9

724,400

-

724,400

Closing equity shareholders' funds at 31 March 2016

216,967,815

12,338,786

229,306,601

 

The accompanying notes form an integral part of these audited financial statements.

 

Statement of Cash Flows

For the year ended 31 March 2017

 

 

 

Year ended

31 March 2017

Year ended

31 March 2016

Cash flow from operating activities

Loss for the year

(3,275,582)

(14,237,001)

Adjustments for:

Net gain on investment at fair value through profit or loss

 

(13,973,386)

 

(8,737,367)

Dividend received

290,041

-

Unrealised foreign exchange (gain) / loss on forwards

 

(4,479,201)

 

2,442,639

Increase in other receivables and prepayments

(8,647)

(4,946)

Purchase of investment at fair value through profit or loss

 

-

 

(5,500,000)

Proceeds from sale of investment at fair value through profit or loss

 

39,200,000

 

31,571,000

Increase in other payables and accrued expenses

503,114

155,764

Net cash inflow from operating activities

18,256,339

5,690,089

Cash flow from financing activities

Proceeds from placing programme

-

724,400

Ordinary Shares repurchased during the year

(7,564,758)

-

Dividends paid

(11,369,793)

(12,842,680)

Net cash flows used in financing activities

(18,934,551)

(12,118,280)

Net decrease in cash and cash equivalents

(678,212)

(6,428,191)

Cash and cash equivalents at start of the year

1,785,849

8,214,040

Cash and cash equivalents at end of the year

1,107,637

1,785,849

Supplemental disclosure of non-cash flow information

Interest received in specie

42,123,590

-

Purchases of investment at fair value through profit or loss during the year in specie

 

(42,123,590)

 

-

-

-

 

The accompanying notes form an integral part of these audited financial statements.

 

Notes to the Audited Financial Statements

For the year ended 31 March 2017

 

1. General Information

The Company is a non-cellular company limited by shares and was registered in Guernsey under the Companies (Guernsey) Law, 2008 (as amended) (the "Companies Law") on 3 November 2011 with registered number 54200 as a closed-ended investment company. The Company's Ordinary Shares are listed on the FCA's Official List and on the main market of the London Stock Exchange.

 

The registered office and principal place of business of the Company is BNP Paribas House, St Julian's Avenue, St Peter Port, Guernsey, GY1 1WA.

 

The Company controls its subsidiary, Alcentra European Floating Rate Income S.A. (the "Subsidiary"), through a holding of 100% (31 March 2016: 100%) of its shares. The Subsidiary is domiciled in Luxembourg and has no subsidiaries. No financial or other support was provided without a contractual obligation to do so during the reporting period. As at 31 March 2017, there were no significant restrictions on the ability of the Subsidiary to transfer funds to the Company in the form of redemption of the shares held by the Company.

 

The Company's investment objective is to provide its shareholders with regular quarterly dividends and the opportunity for capital growth by utilising the skills of the Investment Manager in selecting suitable investments. To pursue its investment objective, the Company uses net issue proceeds to invest into Profit Participating Bonds issued by the Subsidiary. The Subsidiary then uses these proceeds to invest in floating rate, secured loans or high-yield bonds issued by European or US corporate entities predominantly rated below investment grade or deemed by the Investment Manager to be of corresponding credit quality.

 

The Company expects at least 80% of the Subsidiary's investments to be debt obligations of corporate entities domiciled or with significant operations in Western Europe (including the United Kingdom). Investments are expected to be denominated in Euros, Sterling or US Dollars.

 

Alcentra Limited has been appointed by the Company as the Investment Manager and the administration of the Company is delegated to BNP Paribas S.C.A., Guernsey Branch (the "Administrator").

 

2. Going Concern

Going concern refers to the assumption that the Company has the resources to continue in operation for the foreseeable future being twelve months from the date of approval of the financial statements. The Directors believe that it is appropriate to adopt the going concern basis in preparing these audited financial statements based on the following assessment:

 

1. Working capital - As at 31 March 2017, the working capital surplus in the Company was approximately €3.2 million. The Company has the ability to sell bonds in the Subsidiary and/or request repayment of accrued interest. The Subsidiary has a working capital surplus of approximately €1.4 million.

 

2. Closed-ended company - The Company has been registered with the GFSC as a registered closed-ended collective investment scheme. As such shareholders have no right to have their Ordinary Shares redeemed, and therefore no cash flows out of the Company in this respect.

 

3. In accordance with the Articles of Incorporation, a continuation resolution was passed at the AGM on 25 September 2014. The next continuation resolution will be considered at the AGM on 20 September 2017. If the continuation resolution is not passed, the Directors shall put proposals to the shareholders for the reconstruction or reorganisation of the Company. The Board have a reasonable expectation that the continuation resolution will be passed.

 

4. Discount Control Mechanism - the Company's Ordinary Shares did not trade at an average discount in excess of 5% of the NAV per share over the Discount Calculation Period ended 31 March 2017 and as a result the Discount Control Mechanism has not been triggered. The Company has repurchased Ordinary Shares in the market for cancellation to assist in controlling the discount in the Ordinary Share price to NAV per Ordinary Share. Although the Board operates an active discount management policy to mitigate any discount to NAV per Ordinary Share, there can be no guarantee that they will do so or that such mechanisms will be successful. Please refer to the Executive Summary for details regarding the Discount Control Mechanism and Redemption Offer and note 9 for details of Ordinary Share buybacks.

 

Taking into consideration the analysis detailed above, the Company's ability to meet its liabilities as they fall due and reasonably manage any uncertainties as they arise, and after making enquiries of the Company's Investment Manager and Corporate Brokers, the Directors are satisfied that it is appropriate to continue to prepare the financial statements on a going concern basis.

 

3. Accounting Policies

The principal accounting policies applied in the preparation of these financial statements are set out below. These policies have been consistently applied throughout the year presented.

 

3.1. Basis of Preparation

(a) Statement of Compliance

The audited financial statements for the year ended 31 March 2017 have been prepared in accordance with International Financial Reporting Standards as adopted by the European Union ("IFRS") which comprise standards and interpretations approved by the International Accounting Standards Board together with the interpretations of the International Accounting Standards and Standing Interpretations Committee as approved by the International Accounting Standards Committee which remain in effect. They give a true and fair view of the Company's affairs and comply with the Companies Law.

 

The Directors have determined that the Company continues to meet the investment entity criteria. Therefore, in accordance with the investment entity exemption within IFRS 10 - Consolidated Financial Statements, the Company has prepared individual audited financial statements and measures its investment in the Subsidiary at fair value.

 

As detailed in note 2, the financial statements have been prepared on a going concern basis. The Directors are satisfied that, at the time of approving the financial statements, it is appropriate to adopt the going concern basis in preparing the financial statements.

 

(b) Basis of Measurement

These financial statements have been prepared on a historical cost basis adjusted to take account of the revaluation of the investment at fair value through profit or loss.

 

(c) Critical Accounting Judgements and Key Sources of Estimation Uncertainty

The preparation of the audited financial statements in accordance with IFRS requires management to make judgements, estimates and assumptions that affect the application of policies and the reported amounts of assets and liabilities, income and expenses. The estimates and associated assumptions are based on historical experience and various other factors that are believed to be reasonable under the circumstances, the results of which form the basis of making judgements about carrying values of assets and liabilities that are not readily apparent from other sources. Actual results may differ from these estimates.

 

The estimates and underlying assumptions are reviewed on an ongoing basis. Revisions to accounting estimates are recognised in the period in which the estimate is revised if the revision affects only that period, or in the period of the revision and future periods, if the revision affects both current and future periods. Information about critical judgements in applying accounting policies that have the most significant effect on the amounts recognised in the audited financial statements are set out in the paragraph below, Functional and Presentation Currency, and in note 3.3. Information about significant areas of estimation uncertainty that have the most significant effect on the amounts recognised in the audited financial statements are set out in note 7.

 

Functional and Presentation Currency

The Company's functional and presentation currency is Euro, which is the currency of the primary economic environment in which it operates. The Company's performance is evaluated and its liquidity is managed in Euro. Euro is therefore considered as the currency that most faithfully represents the economic effects of the underlying transactions, events and conditions.

 

(d) New Standards, Amendments and Interpretations

Standards, amendments and interpretations to existing standards that become effective in future accounting periods and have not been adopted by the Company are as follows:

 

IFRS

Effective for annual periods beginning on or after

IFRS 9 - Financial Instruments

1 January 2018

IFRS 15 - Revenue from Contracts with Customers

1 January 2018

Amendments to IAS 7 - Statement of Cash Flows (subject to EU endorsement)

 

1 January 2017

 

The Directors have not yet fully assessed the impact these new standards will have on the financial statements but their initial opinion is that it will not be significant.

 

3.2. Foreign Currency Translation

Transactions in currencies other than the functional currency are recorded using the exchange rate prevailing at the transaction date. Foreign exchange gains and losses resulting from the settlement of such transactions, and those from the translation at year end exchange rates of monetary assets and liabilities denominated in foreign currencies are recognised in profit or loss in the Statement of Comprehensive Income.

 

3.3. Investments at Fair Value Through Profit or Loss

(a) Recognition and Initial Measurement

Financial assets and liabilities at fair value through profit or loss are recognised initially on the trade date at which the Company becomes a party to the contractual provisions of the instrument. Other financial assets and liabilities are recognised on the date they originated.

 

(b) Classification

The Company measures its investment in the Subsidiary as a financial asset at fair value through profit or loss. The underlying investments of the Subsidiary are purchased principally for capital growth and income generation and the Subsidiary's portfolio is managed, and performance evaluated, on a fair value basis in accordance with the Company's documented investment strategy.

 

Forward foreign exchange contracts entered into by the Company are designated as held for trading and classified as fair value through profit or loss.

 

The Company has designated certain of its financial instruments, including cash and cash equivalents and dividends at their carrying amounts which approximate to their fair value due to their immediate or short-term maturity.

 

(c) Derecognition

Derecognition of financial assets occur when the rights to receive cash flows from financial instruments expire or are transferred and substantially all of the risks and rewards of ownership have been transferred.

 

On derecognition of a financial asset, the difference between the weighted average carrying amount of the asset (or the carrying amount allocated to the portion of the asset derecognised), and consideration received (including any new asset obtained less any liability assumed), is recognised in profit or loss.

 

The Company derecognises a financial liability when its contractual obligations are discharged, cancelled or expired.

 

(d) Measurement and Valuation

Investments at fair value through profit or loss is the fair value of the Subsidiary measured at its NAV, which includes the fair value of the Subsidiary's investments.

 

3.4. Realised and Unrealised Gains and Losses

Investment transactions are recorded on the trade date. Realised gains and losses arising on the disposal of investments are calculated by reference to the weighted average cost attributable to those investments and the sale proceeds and are included in profit or loss in the Statement of Comprehensive Income. All changes in fair value are recognised in profit or loss in the Statement of Comprehensive Income as net gain on investment at fair value through profit or loss.

 

Forward foreign exchange contracts are recorded on the trade date. Realised gains and losses arising on the expiry of forward foreign exchange contracts are included in profit or loss in the Statement of Comprehensive Income.

 

Unrealised gains and losses arising on the difference between the forward rate and the contract rate on the forward foreign exchange contracts held at the reporting date are also included in profit or loss in the Statement of Comprehensive Income.

 

3.5. Income

Interest income in profit or loss in the Statement of Comprehensive Income includes bank interest. Interest income is recognised on an accruals basis.

 

3.6. Expenses

All expenses are recognised in profit or loss in the Statement of Comprehensive Income on an accruals basis. Costs incurred on the issuance of shares are netted off against the share issue proceeds.

 

3.7. Placing Costs

The expenses incurred on a Placing Programme include placing fees and commissions, registration, listing and admission fees, the cost of settlement and escrow arrangements, printing, advertising and distribution costs, legal fees, and any other applicable expenses incurred in connection with a Placing Programme.

 

3.8. Cash and Cash Equivalents

Cash and cash equivalents include cash in hand and deposits held at call with banks. Cash equivalents are short term, highly liquid investments with original maturities of three months or less that are readily convertible to known amounts of cash and are subject to an insignificant risk of changes in value.

 

3.9. Taxation

The Company has applied for and been granted exemption from liability to income tax in Guernsey under the Income Tax (Exempt Bodies) (Guernsey) Ordinance, 1989 as amended by the Director of Income Tax in Guernsey for the current period. The exemption must be applied for annually and will be granted, subject to the payment of an annual fee, which is currently fixed at £1,200 per applicant, provided the Company qualifies under the applicable legislation for exemption.

 

It is the intention of the Directors to conduct the affairs of the Company so as to ensure that it continues to qualify for exempt company status for the purposes of Guernsey taxation.

 

3.10. Dividends

In any financial year, the Company will aim to pay regular quarterly dividends to shareholders subject to the solvency test prescribed by the Companies Law. It is expected that a distribution will be made by way of a dividend with respect to each calendar quarter.

 

The Directors in their absolute discretion can offer a scrip dividend alternative to shareholders when a cash dividend is declared from time to time.

 

Distributions to the shareholders are recorded through the Statement of Changes in Shareholders' Equity when they are declared to shareholders.

 

3.11. Derivatives

The Company hedges the value of any non-Euro assets held at Subsidiary level into Euro using spot and forward foreign exchange contracts rolling on a monthly basis and, in relation thereto, has entered into a hedging master agreement with BNP Paribas Securities Services S.C.A. ("BNPP"). Under the same hedging master agreement, the Company hedges the value of any non-Euro share classes in their original currency against the Euro on a rolling-monthly basis.

 

The Company estimates fair values of forward foreign exchange contracts based on the latest available forward exchange rates extrapolated to the contract maturity date.

 

The Company does not apply hedge accounting.

 

3.12. Share Capital

Ordinary Shares are classified as equity in accordance with IAS 32 - Financial Instruments: Presentation as these instruments include no contractual obligation to deliver cash.

 

4. Material Agreements

 

a) Investment Management Agreement

Under the terms of the Investment Management Agreement dated 9 January 2012, amended on 21 July 2014, the Company appointed the Investment Manager to provide management services to the Company. The Investment Manager is entitled to a management fee which is calculated and accrued daily at a rate equivalent to 0.70% per annum based on the NAV of the Company. The management fee is payable quarterly in arrears by the Company. The Investment Manager is not entitled to any incentive or performance based fee.

 

b) Administration and Custodian Agreement

The Company has engaged the services of the Administrator, to provide administration and custodian services. Under the terms of the administration and custodian agreement dated 9 January 2012, the Administrator is entitled to the following fees per annum:

 

On first £100m of the NAV 0.075%

On £100m to £250m of the NAV 0.050%

On £250 to £500m of the NAV 0.030%

Any amount greater than £500m of the NAV 0.020%

 

The Administrator is entitled to an annual minimum fee of €113,000.

 

The Administrator is entitled to the following loan administration fee per annum:

 

Less than £500m of the NAV 0.035%

Any amount greater than £500m of the NAV 0.020%

 

The Administrator is entitled to an annual minimum fee of €40,000 for loan administration.

 

The Company Secretary, BNP Paribas S.C.A., Guernsey Branch, is entitled to an annual fee of €41,000 plus fees for ad-hoc board meetings and services of €3,000 per meeting and plus ad-hoc placing programme fee of £600 per placing.

 

c) Registrar's Agreement

Capita Registrars (Guernsey) Limited has been appointed as registrar of the Company pursuant to the Registrar Agreement dated 9 January 2012. The fee is charged at a rate of £2.00 per holder of Ordinary Shares appearing on the register during the fee year, with a minimum charge per annum of £8,250.

 

d) Broker Agreements

The Company, the Investment Manager and J.P Morgan Securities Plc (the "Broker") entered into a Sponsor's and Placing Agreement on 22 April 2014, in connection with the Placing Programme, Initial Placing and Offer for Subscription to issue up to 350 million new Ordinary Shares. The Placing Agreement was governed by the laws of England. The Placing Programme was closed on 21 April 2015.

 

On 28 June 2016, the Company and the Broker entered into an agreement to provide the Company with a shareholder analysis service and access to their system CBSDirect. The Broker is paid an annual fee of £2,000.

 

On 14 September 2016, the Company and the Broker entered into an agreement to implement a share buyback programme, allowing the Broker to buy back the Company's Ordinary Shares where they are trading at a discount of at least 9% to NAV up to a total of up to 1.5 million Ordinary Shares. The Broker is entitled to charge commission at a rate of 0.2% of the price paid for the Ordinary Shares.

 

e) Hedging Master Agreement

The Company and the Administrator entered into an International Forward Foreign Exchange Master Agreement dated 9 January 2012 (the "Hedging Master Agreement"), pursuant to which the parties enter into foreign exchange transactions with the intention of hedging against fluctuations in the exchange rate between the Euro and other currencies. The Hedging Master Agreement is governed by the laws of England and Wales. Note 7 details the gross derivative asset and liability position by contract type and the amount for these derivatives contracts.

 

5. Basic and Diluted Earnings per Ordinary Share

 

31 March 2017

31 March 2017

31 March 2016

31 March 2016

In Euro

In Sterling

In Euro

In Sterling

Total comprehensive loss for the year

€(3,275,582)

£(2,793,842)

€(14,237,001)

£(11,257,766)

Weighted average number of Ordinary Shares in issue during the year

173,745,340

173,745,340

175,966,398

175,966,398

Basic and diluted loss per Ordinary Share

(1.8853)c

(1.6080)p

(8.0907)c

(6.3977)p

 

6. NAV per Ordinary Share

 

31 March 2017

31 March 2017

31 March 2016

31 March 2016

In Euro

In Sterling

In Euro

In Sterling

NAV

€207,096,468

£176,638,790

€229,306,601

£181,321,902

Number of Ordinary Shares in issue at year end

169,610,896

169,610,896

175,975,961

175,975,961

NAV per Ordinary Share

122.1009c

104.1435p

130.3056c

103.0379p

 

7. Financial Assets and Liabilities Designated at Fair Value Through Profit or Loss

 

The Company's investment at fair value through profit and loss is the Profit Participating Bonds it holds in the Subsidiary. The fair value of the Profit Participating Bonds is based on the NAV of the Subsidiary, which has been prepared in accordance with IFRS.

 

Fair values of the Company's forward foreign exchange contracts are determined with reference to the forward exchange rates applicable as at valuation date.

 

Fair Value Hierarchy

The Company categorises its financial assets according to the following fair value hierarchy, that reflects the significance of the inputs used in determining their fair values:

 

Level 1: Inputs that reflect unadjusted price quotes in active markets for identical assets or liabilities that the Company has the ability to access at the measurement date;

 

Level 2: Inputs that reflect price quotes of similar assets and liabilities in active markets, and price quotes of identical assets and liabilities in markets that are considered to be less than active as well as inputs other than price quotes that are observable for the asset or liability either directly or indirectly; and

 

Level 3: Inputs that are unobservable for the asset or liability and reflect the Investment Manager's own assumptions.

 

When observable prices are not available, the Investment Manager may use one or more valuation methods for which sufficient and reliable data is available. Within Level 3, the use of the market approach generally consists of using comparable market transactions, while the use of the income approach generally consists of the net present value of estimated future cash flows, adjusted as appropriate for liquidity, credit, market and/or other risk factors.

 

The inputs used in estimating the value of Level 3 investments include the original transaction price, recent transactions in the same or similar instruments, completed or pending third-party transactions in the underlying investment or comparable issuers, subsequent rounds of financing, recapitalisations and other transactions across the capital structure, offerings in the equity or debt capital markets, and changes in financial ratios or cash flows. Level 3 investments may also be adjusted to reflect illiquidity and/or non-transferability, with the amount of such discount estimated by the Investment Manager in the absence of market information.

 

The following table details the Company's fair value hierarchy.

 

31 March 2017

Level 1

Level 2

Level 3

Total

Financial assets

Investment at fair value through profit or loss

-

-

203,860,076

203,860,076

Derivative assets

-

3,047,851

-

3,047,851

 

31 March 2016

Level 1

Level 2

Level 3

Total

Financial assets

Investment at fair value through profit or loss

-

-

229,376,731

229,376,731

Financial liabilities

Derivative liabilities

-

(1,431,350)

-

(1,431,350)

 

Reconciliation of the Company's Financial Assets Categorised Within Level 3

The following table shows a reconciliation of all movements in the fair value of financial assets categorised within Level 3 during the reporting year.

 

31 March 2017

31 March 2016

Opening balance

229,376,731

246,710,364

Purchases during the year

-

5,500,000

Capitalised interest during the year

42,123,590

-

Return of capital during the year

(39,200,000)

(31,571,000)

Net gain on investment at fair value through profit or loss

13,973,386

8,737,367

Dividend received

(290,041)

-

Interest received in specie

(42,123,590)

-

Closing balance

203,860,076

229,376,731

 

During the years ended 31 March 2017 and 31 March 2016, there were no reclassifications between levels of the fair value hierarchy.

 

As at 31 March 2016, accumulated interest of €42,123,590 was due to the Company by the Subsidiary. On 4 January 2017, the Subsidiary elected to pay the interest due to the Company by way of the issue and allocation to the Company of new Profit Participating Bonds for which no cash payment was required.

 

Company's Investment in the Subsidiary

The NAV of the Subsidiary predominantly comprises the fair values of the investment portfolio of the Subsidiary consisting of Level 1, Level 2 and Level 3 investments and other financial assets and liabilities at carrying value, which together form the NAV of the Subsidiary.

 

The investments in the Subsidiary's portfolio are valued as follows:

 

Fair values of debt instruments are initially based on price quotes, where available. Price quotes are sourced from the Company's approved pricing providers. The approved pricing providers source price quotes from brokers/market makers and determine an average bid price based on the quotes obtained, after adjusting for outliers as identified by the approved pricing providers.

 

Where price quotes are unavailable, the Investment Pricing Committee of the Investment Manager determines fair value using valuation techniques. Valuation techniques used include comparison to similar instruments for which market observable prices exist. Assumptions and inputs used in the valuation technique include interest rates and credit spreads used in estimating discount rates. The Investment Pricing Committee has applied judgment and estimation and used significant unobservable inputs in selecting the appropriate valuation technique used, consideration of identical or similar instruments, and selection of appropriate discount rates.

 

As at 31 March 2017 and 31 March 2016, the fair value measurement of the Profit Participating Bonds is categorised into Level 3 within the fair value hierarchy. This classification reflects the Company's ability to redeem its investment in the Subsidiary on the reported date at the NAV and whether adjustments to the NAV are required to reflect the inherent uncertainty in the timing and range of possible outcomes of any realisation between the NAV and the ultimate recoverable amount. The fair value level of the investment in the Subsidiary reflects management's consideration that this investment is not readily tradable. Management has considered that there are no reasonably possible alternatives in determining the fair value of the Subsidiary.

 

The fair value of the Subsidiary is predominantly influenced by the fair value determination of the underlying debt investments held by the Subsidiary. The Company recognises any transfers between levels of the fair value hierarchy as at the end of the reporting period during which the change occurred.

 

The following table provides a reconciliation of the Company's investment in the Subsidiary measured at fair value:

 

31 March 2017

31 March 2016

Subsidiary's investments at fair value through profit and loss

202,478,555

222,421,036

Subsidiary's derivative assets

-

471,259

Subsidiary's net current assets

1,381,521

6,484,436

Balance as at end of the year

203,860,076

229,376,731

 

As at 31 March 2017, the net gain on the Company's investment in the Subsidiary included in the Statement of Comprehensive Income amounted to €13,973,386 (31 March 2016: €8,737,367), the breakdown of the gain is detailed in the table below:

 

31 March 2017

31 March 2016

Investment income

11,939,070

14,727,003

Realised (loss) /gain on investments at fair value through profit or loss

 

(5,218,024)

 

4,528,665

Realised gain on forward currency contracts

7,608,092

5,615,813

Unrealised loss on investments at fair value through profit or loss

 

(159,874)

 

(16,826,565)

Unrealised (loss) / gain on forward currency contracts

-

792,471

Dividend paid to the Company

(77,398)

-

Expenses

(118,480)

(100,020)

Total

13,973,386

8,737,367

 

Subsidiary Financial Assets and Liabilities Designated at Fair Value Through Profit or Loss

 

The following table details the investment holding of the Subsidiary, categorising these assets by level, according to the fair value hierarchy. The disclosures have been included to provide an insight to shareholders of the asset class mix held by the Subsidiary.

 

31 March 2017

Level 1

Level 2

Level 3

Total

Financial assets

Interest bearing securities

Corporate bonds and debt instruments

2,407,218

195,210,772

4,860,565

202,478,555

Total

2,407,218

195,210,772

4,860,565

202,478,555

 

With effect from August 2016 all forward foreign exchange contracts are held in the Company and not the Subsidiary.

 

31 March 2016

Level 1

Level 2

Level 3

Total

Financial assets

Interest bearing securities

Corporate bonds and debt instruments

23,509,236

195,548,600

3,363,200

222,421,036

Derivatives financial instruments

Forward currency contracts

-

471,259

-

471,259

Total

23,509,236

196,019,859

3,363,200

222,892,295

 

8. Other Payables and Accrued Expenses

 

31 March 2017

31 March 2016

Investment management fees

853,371

265,426

Administration and company secretarial fees

14,753

16,302

Audit fees

60,578

39,477

Other expenses

7,010

31,270

Loan administration fees

6,195

7,010

Printing fees

2,009

2,941

Director fees and travel expenses

13,144

14,139

Registrar fees

6,505

4,857

Broker fees

-

79,029

Total

963,565

460,451

 

The Company has financial risk management policies in place to ensure that all payables are paid within the credit time frame. The Directors considers that the carrying amount of all payables approximates to their fair value.

 

9. Share Capital

The authorised share capital of the Company is represented by an unlimited number of Ordinary Shares with or without a par value, which upon issue, the Directors may designate as: (a) Ordinary Shares; (b) B Shares; (c) C Shares, in each case of such classes and denominated in such currencies as the Directors may determine. Since inception of the Company, no B or C shares have been issued.

 

Since inception of the Company, only Sterling Ordinary Shares have been issued, but the Company has the authority to issue Euro Ordinary Shares.

 

The Company had issued and fully paid up share capital as follows:

 

31 March 2017

31 March 2016

Sterling Ordinary Shares

Sterling Ordinary Shares

Ordinary Shares of no par value

Issued and fully paid

169,610,896

175,975,961

 

Rights attached to Ordinary Shares

The Company's share capital may be denominated in Sterling and Euro. At any general meeting of the Company each Euro share carries one vote and each Sterling share carries 1.2 votes. The shares also carry rights to receive all income and capital available for distribution by the Company.

 

Share Buybacks

The Directors operate an active discount management policy through the use of share buybacks. On 21 September 2016, the Directors were granted authority to repurchase 26,378,796 Ordinary Shares for cancellation or to be held as treasury shares. This authority will expire at the next AGM which will be held on 20 September 2017.

 

To assist in controlling the discount in the Ordinary Share price to NAV per Ordinary Share, during the year ended 31 March 2017, the Company used this authority to repurchase and cancel 6,365,065 Ordinary Shares in the market at a total cost of €7,564,758 (£6,345,793).

 

Significant Share Movements

31 March 2017

31 March 2016

Number

Number

Balance at start of the year

175,975,961

216,967,815

175,475,961

216,243,415

Shares issued under Placing Programme

 

-

 

-

 

500,000

 

724,400

Ordinary Shares repurchased and cancelled during the year

 

(6,365,065)

 

(7,564,758)

 

-

 

-

Balance at end of the year

169,610,896

209,403,057

175,975,961

216,967,815

 

10. Dividends

In any financial year, the Company will aim to pay regular quarterly dividends to shareholders subject to the solvency test prescribed by the Companies Law. It is expected that a distribution will be made by way of a dividend with respect to each calendar quarter. Immediately after the distribution of dividends the Board of Directors is of the opinion that the Company will satisfy the solvency test.

 

The Directors in their absolute discretion can offer a scrip dividend alternative to shareholders when a cash dividend is declared from time to time.

 

The Company has declared and paid the following dividends to its shareholders:

 

Year ended

31 March 2017

Date declared

Payment date

Amount per share

Amount

1 January 2016 to

31 March 2016

 

14 April 2016

 

13 May 2016

 

1.34p

 

€2,991,042

1 April 2016 to

30 June 2016

 

14 July 2016

 

12 August 2016

 

1.52p

 

€3,210,046

1 July 2016 to

30 September 2016

 

13 October 2016

 

11 November 2016

 

1.42p

 

€2,770,785

1 October 2016 to

31 December 2016

 

13 January 2017

 

12 February 2017

 

1.22p

 

€2,397,920

Total

€11,369,793

 

Year ended

31 March 2016

Date declared

Payment date

Amount per share

Amount

1 January 2015 to 31 March 2015

 

15 April 2015

 

15 May 2015

 

1.26p

 

€3,083,820

1 April 2015 to 30 June 2015

 

16 July 2015

 

14 August 2015

 

1.37p

 

€3,448,042

1 July 2015 to 30 September 2015

 

15 October 2015

 

13 November 2015

 

1.42p

 

€3,452,082

1 October 2015 to 31 December 2015

 

13 January 2016

 

12 February 2016

 

1.24p

 

€2,858,736

Total

€12,842,680

 

11. Reconciliation of NAV to Published NAV

31 March 2017

31 March 2016

NAV

NAV per share

NAV

NAV per share

Published NAV

208,163,997

1.2273

230,724,229

1.3111

Impact of fair value adjustment on investments held by the Subsidiary1

 

(1,067,529)

 

(0.0063)

 

(1,417,628)

 

(0.0080)

NAV attributable to shareholders

207,096,468

1.2210

229,306,601

1.3031

 

1 The investments held by the Subsidiary have been valued at bid price which is consistent with the basis used in the prior year audited financial statements.

 

12. Risk Management Policies and Procedures

This note presents information about the Company's exposure to risks. The majority of the Company's assets are invested in the Subsidiary through Profit Participating Bonds, therefore the majority of the risks that the Company is exposed to are borne out of the indirect exposure to the risks of the underlying portfolio held at the Subsidiary level.

 

The Board of Directors has established procedures for monitoring and controlling risk. The Company has investment guidelines that set out its overall business strategies, its tolerance for risk and its general risk management philosophy.

 

In addition, the Investment Manager monitors and measures the overall risk bearing capacity in relation to the aggregate risk exposure across all risk types and activities.

 

Market risk

The fair value of the Company's investment into the Subsidiary may fluctuate due to changes in market prices of the underlying portfolio of investments held by the Subsidiary. Market risk comprises market price risk, currency risk and interest rate risk. The Investment Manager moderates the risk through a careful selection of investments within specified limits. The maximum risk resulting from financial assets is determined by the fair value of the financial assets. The Company's overall market position at Company and Subsidiary level is monitored by the Investment Manager and is reviewed by the Board of Directors on an ongoing basis. The main market risk measures used by the Investment Manager are rolling 12 month volatility. Volatility is used as a standard market risk metric versus the Company's benchmark volatility.

 

Market price risk

The Company's investment at fair value through profit or loss is based on the NAV of the Subsidiary which is susceptible to the market price risk arising from uncertainties about future prices of the underlying portfolio of investments held by the Subsidiary.

 

The Board of Directors manages the risks inherent in the investment by ensuring full and timely reporting of the relevant information from the Investment Manager. Investment performance is reviewed at each Board meeting. The Board of Directors monitor the Investment Manager's compliance with the Company's objectives. At 31 March 2017, the overall market exposure of the Company is equivalent to the fair value of the underlying portfolio of investments held by the Subsidiary was €202,478,555 (31 March 2016: €222,421,036).

 

Market price risk sensitivity

The following table illustrates the sensitivity of the return for the year and the Company's net assets to an increase or decrease of 5% in the fair values of the underlying portfolio of investments held by the Subsidiary at the reporting date.

 

This level of change is considered to be reasonable based on observation of current market conditions.

31 March 2017

31 March 2016

Increase in fair value

Decrease in fair value

Increase in fair value

Decrease in fair value

Profit/(loss) for the financial year

 

10,123,928

 

(10,123,928)

 

11,121,052

 

(11,121,052)

Net assets

10,123,928

(10,123,928)

11,121,052

(11,121,052)

 

Currency risk

The functional and presentation currency of the Company and its Subsidiary is Euro. The Company invests in its Subsidiary which in turn invests in financial instruments and enters into transactions that are denominated in currencies other than its functional currency, primarily in US Dollars and Sterling. Consequently, the Company is exposed to risk that the exchange rate of its functional currency relative to other foreign currencies may change in a manner that has an adverse effect on the fair value or future cash flows of that portion of the Company's financial assets or liabilities.

 

The Investment Manager monitors the exposure to foreign currencies and reports to the Board of Directors on a regular basis. The Investment Manager measures the risk of the foreign currency exposure by considering the effect on the NAV and income of a movement in the rates of exchange to which the assets, liabilities, income and expenses are exposed.

 

The Company also enters into forward foreign currency contracts to manage its exposure to currency risk due to the assets being in Euro and the issuance of shares in Sterling.

 

With effect from August 2016, the Company entered into forward foreign currency contracts to manage its exposure to non-Euro investments in the portfolio of the Subsidiary. Prior to August 2016 these contracts were held at Subsidiary level.

 

The Investment Manager seeks to engage in currency hedging contracts such as forward currency exchange contracts being available in a timely manner and on terms acceptable to them, in their sole and absolute discretion. The primary aim of the Investment Manager's use of hedging is to protect the Sterling shareholders return.

 

As at 31 March 2017, the Company had the following open forward foreign exchange contracts:

 

Buy/Sell Currency

Bought

Sold

Fair Value / EUR Equivalent

Settlement Date

EUR/GBP

54,635,381

47,500,000

(1,044,115)

10 April 2017

EUR/USD

14,120,983

14,940,000

159,057

10 April 2017

EUR/GBP

285,486

250,000

(7,564)

10 April 2017

GBP/EUR

179,300,000

206,234,185

3,940,473

10 April 2017

Total

3,047,851

 

As at 31 March 2016, the Company had the following open forward foreign exchange contracts:

 

Buy/Sell Currency

Bought

Sold

Fair Value / EUR Equivalent

Settlement Date

GBP/EUR

183,000,000

232,706,002

(1,431,350)

29 April 2016

Total

(1,431,350)

 

As at 31 March 2017, the Subsidiary had no open forward foreign exchange contracts.

 

As at 31 March 2016, the Subsidiary had the following open forward foreign exchange contracts:

 

Buy/Sell Currency

Bought

Sold

Fair Value / EUR Equivalent

Settlement Date

EUR/GBP

73,118,006

57,500,000

450,0411

29 April 2016

EUR/USD

5,527,151

6,270,000

21,2181

29 April 2016

Total

471,259

 

The table below detail the carrying amounts of the Company's financial assets and liabilities that have foreign currency exposure:

 

31 March 2017

GBP

EUR

USD

Total

Investment in Subsidiary at fair value through profit or loss

 

-

 

203,860,076

 

-

 

203,860,076

Other receivables and prepayments

 

23,900

 

20,569

 

-

 

44,469

Derivative assets

-

3,047,851

-

3,047,851

Cash and cash equivalents

45,318

1,062,319

-

1,107,637

Other payables and accrued expenses

 

(92,663)

 

(870,902)

 

-

 

(963,565)

Total net foreign currency exposure

 

(23,445)

 

207,119,913

 

-

 

207,096,468

Forward hedging

151,313,318

(137,192,335)

(14,120,983)

-

Exposure net of forward hedging2

 

151,289,873

 

69,927,578

 

(14,120,983)

 

207,096,468

 

31 March 2016

GBP

EUR

Total

Investment in Subsidiary at fair value through profit or loss

 

-

 

229,376,731

 

229,376,731

Other receivables and prepayments

 

35,822

 

-

 

35,822

Derivative liabilities

-

(1,431,350)

(1,431,350)

Cash and cash equivalents

463

1,785,386

1,785,849

Other payables and accrued expenses

 

(175,251)

 

(285,200)

 

(460,451)

Total net foreign currency exposure

 

(138,966)

 

229,445,567

 

229,306,601

Forward hedging

232,706,002

(232,706,002)

-

Exposure net of forward hedging2

 

232,567,036

 

(3,260,435)

 

229,306,601

 

1 These fair values were included within the fair value of the investment in the Subsidiary at fair value through profit or loss.

 

2 With effect from August 2016, the Company entered into forward foreign currency contracts to manage its exposure to non-Euro investments in the portfolio of the Subsidiary. Prior to August 2016 these contracts were held at Subsidiary level.

 

The tables below detail the carrying amounts of the Subsidiary's financial assets and liabilities that have foreign currency exposure:

 

31 March 2017

GBP

EUR

USD

Total

Investments designated at fair value through profit or loss

 

52,254,463

 

137,794,231

 

12,429,861

 

202,478,555

Interest receivable

86,374

1,254,463

29,606

1,370,443

Trade and other receivables

62,824

15,635

5,637

84,096

Cash and cash equivalents

3,434,426

15,811,690

2,470,743

21,716,859

Trade and other payables

(1,172,429)

(33,458,873)

(1,131,961)

(35,763,263)

Total net foreign currency exposure

 

54,665,658

 

121,417,416

 

13,803,886

 

189,886,690

Forward hedging

-

-

-

-

Exposure net of forward hedging

 

54,665,658

 

121,417,416

 

13,803,886

 

189,886,690

 

31 March 2016

GBP

EUR

USD

Total

Investments designated at fair value through profit or loss

 

69,761,514

 

144,064,703

 

8,594,819

 

222,421,036

Interest receivable

87,545

1,765,823

27,549

1,880,917

Trade and other receivables

67,841

509

5,299

73,649

Derivative assets

-

471,259

-

471,259

Cash and cash equivalents

1,389,231

6,364,828

284,986

8,039,045

Trade and other payables

-

(42,481,569)

(3,444,337)

(45,925,906)

Total net foreign currency exposure

 

71,306,131

 

110,185,553

 

5,468,316

 

186,960,000

Forward hedging

(73,118,006)

78,645,157

(5,527,151)

-

Exposure net of forward hedging

 

(1,811,875)

 

188,830,710

 

(58,835)

 

186,960,000

 

Currency sensitivity analysis

Should the value of the Euro against Sterling and US Dollar increase or decrease by 10% with all other variables held constant, the increase and decrease of the comprehensive income and net assets of the Company would be as follows:

 

31 March 2017

31 March 2016

Increase

Decrease

Increase

Decrease

GBP

(12,501,224)

18,340,699

(27,119,540)

19,863,981

USD

1,551,104

(1,242,203)

-

-

 

Should the value of the Euro against Sterling and US Dollar increase or decrease by 10% with all other variables held constant, the increase and decrease of the comprehensive income and net assets of the Subsidiary would be as follows:

 

31 March 2017

31 March 2016

Increase

Decrease

Increase

Decrease

GBP

(5,466,566)

5,466,566

542,367

260,254

USD

(1,380,389)

1,380,389

(28,028)

(47,331)

 

Interest rate risk

Interest rate risk is the risk that the value of financial instruments and related income from the cash and cash equivalents will fluctuate due to changes in market interest rates.

 

The Company's exposure to interest rate risk relates to underlying portfolio of investments held by the Subsidiary and cash and cash equivalents held at both Company and Subsidiary level. The interest rate exposures at Subsidiary level affect the fair value of the investment designated as fair value through profit or loss. As a result the Company is subject to significant amounts of risk due to fluctuations in the prevailing levels of market interest rates.

 

Financial instruments at variable rates expose the Company to cash flow risk. Financial instruments at fixed rates expose the Company to fair value interest rate risk.

 

The table below summarises the Company's exposure to interest rate risks either directly or through its investment in the Subsidiary. It includes all of the Company's and the Subsidiary's assets and liabilities that are interest rate sensitive.

 

31 March 2017

31 March 2016

At variable rate

Investment in underlying portfolio of investments at fair value through profit or loss

202,478,555

222,421,036

Cash and cash equivalents in Company and Subsidiary

22,824,496

9,824,894

Total

225,303,051

232,245,930

Total interest sensitivity gap

225,303,051

232,245,930

 

If interest rates had changed by 100 basis points, with all other variables remaining constant, the effect on the net profit and equity would have been as shown on the table below:

 

31 March 2017

31 March 2016

Increase of 100 basis points

2,253,031

2,322,459

Decrease of 100 basis points

(2,253,031)

(2,322,459)

 

These figures have been calculated after considering the potential interest rate floors and caps on investments held in the Subsidiary's portfolio.

 

As at 31 March 2017, there were no instruments that were limited by an interest rate cap and that the current spread across the portfolio is at such level that a 1% decrease in interest rates will not breach any floors.

 

Credit risk

Credit risk is the risk that a counterparty will be unable to pay amounts in full when due.

 

The Company's main credit risk exposure is indirect via its investment in the Subsidiary since the Subsidiary holds debt in its portfolio. Credit risk in respect of other financial assets comprises cash and cash equivalents and dividend receivable. Counterparty default in an investment or other financial asset at the Subsidiary level would impact fair value of the investment designated at fair value through profit or loss at Company level. The total exposure to credit risk arises from default of the counterparty, and therefore the carrying amounts of the underlying portfolio of investments held by the Subsidiary and other financial assets best represent the maximum credit risk exposure at the year-end date. As at 31 March 2017, the maximum credit risk exposure was €229,829,341 (31 March 2016: €234,231,273).

 

The Investment Manager has adopted procedures to reduce credit risk exposure by conducting credit analysis of the counterparties in the portfolio of the Subsidiary, their business and reputation which is monitored on an ongoing basis.

 

The Company and Subsidiary maintain its cash and cash equivalents, when held, at BNPP, which is subject to the Company's credit risk monitoring policies as mentioned above. The counterparty to the foreign exchange contracts held by the Company and Subsidiary is BNPP.

 

BNP Paribas Securities Services S.C.A., Guernsey Branch, as Custodian, is a branch of BNPP, whose credit ratings are A with Standard & Poor's, A1 with Moody's and A+ with Fitch's.

 

Credit risk arising on debt securities is constantly monitored by the Investment Manager.

 

Counterparty risk

Counterparty risk is defined as risk that trading or depositary counterparties were to default on their obligation.

 

All loan counterparties are approved by the Investment Manager and all trading counterparties are approved and monitored through monthly broker exposure reports and approved broker lists by the Investment Manager.

 

Portfolio credit risk

Credit risk management within the Subsidiary's portfolio is the responsibility of the Investment Manager. The portfolio managers at the Investment Manager are supported by a fundamental approach to credit analysis whereby every asset within each portfolio is regularly monitored by the credit analysis. Quarterly Performance Reviews ("QPR") are performed for each investee company in the Portfolio of the Subsidiary by the Investment Manager.

 

Liquidity risk

Risk that the Company cannot meet cash and collateral obligations at reasonable cost for expected and unexpected needs without adversely affecting daily operations.

 

Liquidity risk in respect of other financial liabilities of the Company are those due to counterparties. However at 31 March 2017 there was sufficient liquidity in the form of cash and cash equivalents to satisfy the Company's obligations.

 

As at 31 March 2017, except for the investment in Subsidiary, each asset is given an internal score by the Investment Manager referring to liquidity.

 

Liquidity risk is measured and monitored by the Investment Manager. The Investment Manager assesses the liquidity of positions within the portfolio of the Subsidiary through their daily interactions with loan market dealers.

The investment portfolio of the Subsidiary is considered to be readily realisable.

 

Operational risk

Operational risk is defined as risk of loss resulting from people, system, inadequate or failed internal processes or external events. Operational risk may arise from errors in transaction processing, breaches of internal control systems and internal or external frauds, damage to physical assets and/or business disruption due to systems failures or other events.

 

The Company's objective is to manage operational risk so as to balance limiting of financial losses and damage to its reputation with achieving its investment objective of generating returns to investors.

 

The Investment Manager works with the Directors to identify the risks facing the Company. The key risks are documented and updated in the Risk Matrix and by the Investment Manager.

 

The primary responsibility for the development and implementation of controls over operational risk rests with the Board of Directors.

 

The responsibility is supported by the development of overall standards for the management of operational risk, which encompasses the controls and processes at the service providers and the establishment of service levels with the service providers.

 

The Directors' assessment over the adequacy of the controls and processes in place at the service providers with respect to operational risk is carried out via regular discussions with the service providers and review of the service providers' ISAE 3402 reports on internal controls (or equivalent) if available.

 

Capital management policies and procedures

The Company's capital management objectives are:

 

· to ensure that the Company will be able to continue as a going concern; and

· to maximise the income and capital return to its equity shareholders through an appropriate balance of equity capital and long-term debt.

 

In accordance with the Company's investment policy, the Company's principal use of cash has been to fund investment in the Subsidiary, as well as initial expenses related to the issue, ongoing operational expenses and payment of dividends and other distributions to shareholders in accordance with the Company's dividend policy.

 

The Directors, with the assistance of the Investment Manager monitor and review the broad structure of the Company's capital on an ongoing basis.

 

The Company has no imposed capital requirements.

 

13. Operating Segments

The Chief Operating Decision Makers of the Company are the Board of Directors. The Directors are of the opinion that the Company is engaged in a single segment of business, being investing, via its Subsidiary, in investments in floating rate, secured loans or high-yield bonds. Segment information is measured on the same basis as those used in the preparation of the Company's audited financial statements with the exception of the valuation of financial instruments. For the purpose of segment reporting, at the Subsidiary level, financial instruments are measured in accordance with the method set out in the Company's prospectus, this being the mid-price of the securities as at the valuation day.

 

The Board of Directors reviews internal management reports on a quarterly basis. The Investment Manager, together with the Administrator and the Company Secretary, ensure that all Directors receive all relevant information in a timely manner.

 

The key measurement of performance used by the Board to assess the Company's performance and to allocate resources is the movement in the NAV which is prepared on a daily basis.

The majority of the Subsidiary's assets are held in Europe and are held in Sterling, Euros and US Dollars.

 

A detailed analysis of the operating segment with respect to geographical disclosures and significant customers is included in the Investment Manager's Report and Directors' Report respectively.

 

The Company's only shareholders with a holding of greater than 10% as at 31 March 2017 were BNY Mellon Investment Management Seed Capital Limited ("BNY Mellon") with a holding of 11.89% and Vidacos Nominees Limited NRWICH4 Acct with a holding of 17.13% (31 March 2016: BNY Mellon with a holding of 15.04% and Vidacos Nominees Limited UKCP 100 Acct with a holding of 15.08%)

 

14. Related Party Transactions

Parties are considered to be related if one party has the ability to control the other party or exercise significant influence over the other party in making financial or operational decisions.

 

Total investment management fees for the year amounted to €1,508,430 (31 March 2016: €1,760,929), with outstanding fees of €853,371 at 31 March 2017 (31 March 2016: €265,426).

 

As at 31 March 2017 BNY Mellon held 20,164,000 (31 March 2016: 26,464,000) shares in the Company. BNY Mellon is wholly owned by the parent company of the Investment Manager.

 

As at 31 March 2017, Mr Fitzgerald held 15,000 (31 March 2016: 15,000) Ordinary Shares in the Company.

 

As at 31 March 2017, Mr Bridel (together with his Spouse) held 5,000 (31 March 2016: 5,000) Ordinary Shares in the Company.

 

As at 31 March 2017, Mrs Ewing (together with her Spouse) held 5,000 (31 March 2016: 5,000) Ordinary Shares in the Company.

 

The Directors of the Company are remunerated per annum as follows:

 

Chairman and Chairman of the Risk Committee and of the Management Engagement Committee - £50,000.

 

Chairman of the Audit Committee - £42,000.

 

Chairman of the Remuneration and Nomination Committee - £40,000.

 

The total Directors' fees and travel expenses for the year amounted to €160,567 (31 March 2016: €139,216), with outstanding fees of €13,144 (31 March 2016: €14,139), due to the Directors at 31 March 2017.

 

15. Events After the Reporting Date

On 11 April 2017, the Company declared a dividend of 1.09p per Ordinary Share, covering the period 1 January 2017 to 31 March 2017. This dividend was paid to the shareholders on 12 May 2017.

 

The Company repurchased 3,240,496 Ordinary Shares subsequent to the year end at a total cost of €3,759,933 (£3,280,779) and the current number of shares in issue is 166,370,400.

 

There were no other events which occurred subsequent to the year-end until the date of approval of the financial statements, which would have a material impact on the financial statements of the Company as at 31 March 2017.

 

Company Information

 

Directors

Ian Fitzgerald (Non-Executive Chairman)

Anne Ewing (Non-Executive Senior Independent Director)

Jonathan Bridel (Non-Executive Director)

 

Registered Office

BNP Paribas House, St Julian's Avenue, St Peter Port, GY1 1WA, Guernsey, Channel Islands

 

Investment Manager

Alcentra Limited

10 Gresham Street, London, EC2V 7JD, United Kingdom

 

Solicitors to the Company (as to English law)

Linklaters LLP 

One Silk Street, London, EC2Y 8HQ, United Kingdom

 

Advocates to the Company (as to Guernsey law)

Carey Olsen,

P.O. Box 98, Carey House, Les Banques, St. Peter Port, GY1 4BZ, Guernsey,  Channel Islands

 

Corporate Broker

J.P. Morgan Securities Plc

25 Bank Street, London, E14 5JP, United Kingdom

 

Auditor

KPMG Channel Islands Limited

Glategny Court, Glategny Esplanade, St Peter Port, GY1 1WR, Guernsey, Channel Islands

 

Registrar

Capita Registrars (Guernsey) Limited

Mont Crevelt House, Bulwer Avenue, St Sampson, GY2 4LH, Guernsey, Channel Islands

 

Principal Bankers

BNP Paribas Securities Services S.C.A. 

BNP Paribas House, St Julian's Avenue, St Peter Port, GY1 1WA, Guernsey, Channel Islands

 

Designated Manager, Administrator, Custodian and Company Secretary

BNP Paribas Securities Services S.C.A., Guernsey Branch

BNP Paribas House, St Julian's Avenue, St Peter Port, GY1 1WA, Guernsey, Channel Islands

 

Enquiries:

 

BNP Paribas Securities Services S.C.A., Guernsey Branch

Company Secretary

Jasper Cross

01481 750859

 

JP Morgan Cazenove

William Simmonds

Oliver Kenyon

0207 742 4000

 

Copies of the Company's Annual Report and Audited Financial Statements will be available from the Company Secretary, BNP Paribas Securities Services S.C.A., Guernsey Branch at BNP Paribas House, St Julian's Avenue, St Peter Port, Guernsey, GY1 1WA, or on the Company's website WWW.AEFRIF.COM Neither the contents of the Company's website, nor the contents of any website accessible from hyperlinks on the Company's website (or any other website) is incorporated into, or forms part of, this announcement.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
ACSSEDSAAFWSEEM
Date   Source Headline
3rd Nov 202012:01 pmRNSResult of Extraordinary General Meeting
2nd Nov 20206:00 pmRNSNet Asset Value(s)
30th Oct 20206:00 pmRNSNet Asset Value(s)
29th Oct 20206:00 pmRNSNet Asset Value(s)
28th Oct 20206:00 pmRNSNet Asset Value(s)
27th Oct 20206:00 pmRNSNet Asset Value(s)
26th Oct 20206:00 pmRNSNet Asset Value(s)
23rd Oct 20206:00 pmRNSNet Asset Value(s)
22nd Oct 20206:00 pmRNSNet Asset Value(s)
21st Oct 20206:00 pmRNSNet Asset Value(s)
20th Oct 20206:00 pmRNSNet Asset Value(s)
20th Oct 20202:42 pmRNSCancellation of Treasury Shares
19th Oct 20206:00 pmRNSNet Asset Value(s)
16th Oct 20206:00 pmRNSNet Asset Value(s)
15th Oct 20206:00 pmRNSNet Asset Value(s)
14th Oct 20206:00 pmRNSNet Asset Value(s)
13th Oct 20206:00 pmRNSNet Asset Value(s)
12th Oct 20206:00 pmRNSNet Asset Value(s)
9th Oct 20206:00 pmRNSNet Asset Value(s)
8th Oct 20206:00 pmRNSNet Asset Value(s)
7th Oct 20206:00 pmRNSNet Asset Value(s)
6th Oct 20206:00 pmRNSNet Asset Value(s)
5th Oct 20206:00 pmRNSNet Asset Value(s)
5th Oct 20206:00 pmRNSNotice of EGM
2nd Oct 20206:00 pmRNSNet Asset Value(s)
1st Oct 20206:00 pmRNSNet Asset Value(s)
1st Oct 20203:44 pmRNSTotal Voting Rights
30th Sep 20206:00 pmRNSNet Asset Value(s)
29th Sep 20206:00 pmRNSNet Asset Value(s)
28th Sep 20206:00 pmRNSNet Asset Value(s)
28th Sep 20204:21 pmRNSHolding(s) in Company
25th Sep 20206:00 pmRNSNet Asset Value(s)
24th Sep 20206:00 pmRNSNet Asset Value(s)
24th Sep 20202:55 pmRNSReport of Income for UK Tax Purposes
24th Sep 202011:49 amRNSResult of AGM
23rd Sep 20206:00 pmRNSNet Asset Value(s)
23rd Sep 20203:04 pmRNSHolding(s) in Company
22nd Sep 20206:00 pmRNSNet Asset Value(s)
21st Sep 20206:00 pmRNSNet Asset Value(s)
21st Sep 20204:40 pmRNSSecond Price Monitoring Extn
21st Sep 20204:35 pmRNSPrice Monitoring Extension
18th Sep 20206:00 pmRNSNet Asset Value(s)
17th Sep 20206:00 pmRNSNet Asset Value(s)
16th Sep 20206:00 pmRNSNet Asset Value(s)
15th Sep 20206:00 pmRNSNet Asset Value(s)
14th Sep 20206:00 pmRNSNet Asset Value(s)
14th Sep 20204:24 pmRNSCompletion of Partial Compulsory Redemption
11th Sep 20206:00 pmRNSNet Asset Value(s)
10th Sep 20206:00 pmRNSNet Asset Value(s)
9th Sep 20206:00 pmRNSNet Asset Value(s)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.